
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5346A88AF441D30546A80019707F19.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia">
<meta name="citation_author" content="Yan Nee Gan">
<meta name="citation_author_institution" content="Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author_institution" content="Malaysian Health Technology Assessment Section, Ministry of Health, Putrajaya, Malaysia">
<meta name="citation_author" content="Rafdzah Zaki">
<meta name="citation_author_institution" content="Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author_institution" content="Centre for Epidemiology and Evidence-based Practice (CEBP), Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author" content="Safia Alia Hafidzar">
<meta name="citation_author_institution" content="Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author" content="Kwee Choy Koh">
<meta name="citation_author_institution" content="Department of Medicine, IMU University Clinical Campus, Seremban, Negeri Sembilan, Malaysia">
<meta name="citation_author" content="Mariani Ahmad Nizaruddin">
<meta name="citation_author_institution" content="Department of Community and Pharmacy Practice, Faculty of Pharmacy, University of Cyberjaya, Cyberjaya, Selangor, Malaysia">
<meta name="citation_author" content="Rosnida Mohd Noh">
<meta name="citation_author_institution" content="Department of Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia">
<meta name="citation_author" content="Khairil Erwan Khalid">
<meta name="citation_author_institution" content="Department of Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia">
<meta name="citation_author" content="Andrew Yap">
<meta name="citation_author_institution" content="The Red Clinic, Petaling Jaya, Selangor, Malaysia">
<meta name="citation_author" content="Frederick L Altice">
<meta name="citation_author_institution" content="Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author_institution" content="Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America">
<meta name="citation_author_institution" content="Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America">
<meta name="citation_author_institution" content="Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, Connecticut, United States of America">
<meta name="citation_author" content="Sin How Lim">
<meta name="citation_author_institution" content="Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author_institution" content="Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author" content="Iskandar Azwa">
<meta name="citation_author_institution" content="Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_author_institution" content="Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0328713">
<meta name="citation_doi" content="10.1371/journal.pone.0328713">
<meta name="citation_pmid" content="40824910">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/pdf/pone.0328713.pdf">
<meta name="description" content="Expanding HIV pre-exposure prophylaxis (PrEP) through pharmacies may improve access for key populations. As part of the preparation phase of the EPIS (Exploration-Preparation-Implementation-Sustainment) framework, we developed and evaluated an ...">
<meta name="og:title" content="Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Expanding HIV pre-exposure prophylaxis (PrEP) through pharmacies may improve access for key populations. As part of the preparation phase of the EPIS (Exploration-Preparation-Implementation-Sustainment) framework, we developed and evaluated an ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12360552">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0328713"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0328713.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12360552%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12360552/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12360552/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0328713" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 18;20(8):e0328713. doi: <a href="https://doi.org/10.1371/journal.pone.0328713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gan%20YN%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yan Nee Gan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yan Nee Gan</span></h3>
<div class="p">
<sup>1</sup>Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div class="p">
<sup>2</sup>Malaysian Health Technology Assessment Section, Ministry of Health, Putrajaya, Malaysia</div>
<div>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gan%20YN%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan Nee Gan</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zaki%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rafdzah Zaki</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rafdzah Zaki</span></h3>
<div class="p">
<sup>1</sup>Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div class="p">
<sup>3</sup>Centre for Epidemiology and Evidence-based Practice (CEBP), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div>Conceptualization, Methodology, Project administration, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zaki%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rafdzah Zaki</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hafidzar%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Safia Alia Hafidzar</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Safia Alia Hafidzar</span></h3>
<div class="p">
<sup>4</sup>Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div>Formal analysis, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hafidzar%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Safia Alia Hafidzar</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koh%20KC%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Kwee Choy Koh</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Kwee Choy Koh</span></h3>
<div class="p">
<sup>5</sup>Department of Medicine, IMU University Clinical Campus, Seremban, Negeri Sembilan, Malaysia</div>
<div>Methodology, Resources, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koh%20KC%22%5BAuthor%5D" class="usa-link"><span class="name western">Kwee Choy Koh</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmad%20Nizaruddin%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mariani Ahmad Nizaruddin</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mariani Ahmad Nizaruddin</span></h3>
<div class="p">
<sup>6</sup>Department of Community and Pharmacy Practice, Faculty of Pharmacy, University of Cyberjaya, Cyberjaya, Selangor, Malaysia</div>
<div>Methodology, Resources, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmad%20Nizaruddin%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariani Ahmad Nizaruddin</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mohd%20Noh%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Rosnida Mohd Noh</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Rosnida Mohd Noh</span></h3>
<div class="p">
<sup>7</sup>Department of Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia</div>
<div>Methodology, Resources, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mohd%20Noh%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rosnida Mohd Noh</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khalid%20KE%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Khairil Erwan Khalid</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Khairil Erwan Khalid</span></h3>
<div class="p">
<sup>8</sup>Department of Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia</div>
<div>Methodology, Resources, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khalid%20KE%22%5BAuthor%5D" class="usa-link"><span class="name western">Khairil Erwan Khalid</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yap%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Andrew Yap</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Andrew Yap</span></h3>
<div class="p">
<sup>9</sup>The Red Clinic, Petaling Jaya, Selangor, Malaysia</div>
<div>Methodology, Resources, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yap%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrew Yap</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Altice%20FL%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Frederick L Altice</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Frederick L Altice</span></h3>
<div class="p">
<sup>4</sup>Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div class="p">
<sup>10</sup>Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America</div>
<div class="p">
<sup>11</sup>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America</div>
<div class="p">
<sup>12</sup>Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, Connecticut, United States of America</div>
<div>Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Altice%20FL%22%5BAuthor%5D" class="usa-link"><span class="name western">Frederick L Altice</span></a>
</div>
</div>
<sup>4,</sup><sup>10,</sup><sup>11,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lim%20SH%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sin How Lim</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sin How Lim</span></h3>
<div class="p">
<sup>1</sup>Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div class="p">
<sup>4</sup>Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div>Conceptualization, Methodology, Project administration, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lim%20SH%22%5BAuthor%5D" class="usa-link"><span class="name western">Sin How Lim</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Azwa%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Iskandar Azwa</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Iskandar Azwa</span></h3>
<div class="p">
<sup>4</sup>Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div class="p">
<sup>13</sup>Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div>Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Azwa%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Iskandar Azwa</span></a>
</div>
</div>
<sup>4,</sup><sup>13</sup>
</div>
<div class="cg p">Editor: <span class="name western">Ali Ahmed</span><sup>14</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div id="aff002">
<sup>2</sup>Malaysian Health Technology Assessment Section, Ministry of Health, Putrajaya, Malaysia</div>
<div id="aff003">
<sup>3</sup>Centre for Epidemiology and Evidence-based Practice (CEBP), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div id="aff004">
<sup>4</sup>Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div id="aff005">
<sup>5</sup>Department of Medicine, IMU University Clinical Campus, Seremban, Negeri Sembilan, Malaysia</div>
<div id="aff006">
<sup>6</sup>Department of Community and Pharmacy Practice, Faculty of Pharmacy, University of Cyberjaya, Cyberjaya, Selangor, Malaysia</div>
<div id="aff007">
<sup>7</sup>Department of Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia</div>
<div id="aff008">
<sup>8</sup>Department of Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia</div>
<div id="aff009">
<sup>9</sup>The Red Clinic, Petaling Jaya, Selangor, Malaysia</div>
<div id="aff010">
<sup>10</sup>Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America</div>
<div id="aff011">
<sup>11</sup>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America</div>
<div id="aff012">
<sup>12</sup>Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, Connecticut, United States of America</div>
<div id="aff013">
<sup>13</sup>Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia</div>
<div id="edit1">
<sup>14</sup>Riphah International University, PAKISTAN</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>rafdzah@ummc.edu.my</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Yan Nee Gan</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rafdzah Zaki</span></strong>: <span class="role">Conceptualization, Methodology, Project administration, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Safia Alia Hafidzar</span></strong>: <span class="role">Formal analysis, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Kwee Choy Koh</span></strong>: <span class="role">Methodology, Resources, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mariani Ahmad Nizaruddin</span></strong>: <span class="role">Methodology, Resources, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rosnida Mohd Noh</span></strong>: <span class="role">Methodology, Resources, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Khairil Erwan Khalid</span></strong>: <span class="role">Methodology, Resources, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Andrew Yap</span></strong>: <span class="role">Methodology, Resources, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Frederick L Altice</span></strong>: <span class="role">Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Sin How Lim</span></strong>: <span class="role">Conceptualization, Methodology, Project administration, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Iskandar Azwa</span></strong>: <span class="role">Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Ali Ahmed</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Dec 11; Accepted 2025 Jul 4; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Gan et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12360552  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40824910/" class="usa-link">40824910</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Introduction</h3>
<p>Expanding HIV pre-exposure prophylaxis (PrEP) through pharmacies may improve access for key populations. As part of the preparation phase of the EPIS (Exploration-Preparation-Implementation-Sustainment) framework, we developed and evaluated an online, self-paced PrEP training program for community pharmacists to prepare for a pilot, pharmacy-led PrEP service in Malaysia.</p></section><section id="sec002"><h3 class="pmc_sec_title">Materials and methods</h3>
<p>In May 2023, a PrEP training committee developed an online training program covering PrEP efficacy, safety, eligibility, baseline assessments, laboratory testing, prescribing, and special circumstances, and pre-/post-training knowledge tests. In June 2023, 18 community pharmacists asynchronously completed the training. Effectiveness was evaluated using a 20-question pre-/post-training knowledge test, with responses calculated into percentage scores, alongside participant feedback. Paired t-tests assessed knowledge score differences (p &lt; 0.05).</p></section><section id="sec003"><h3 class="pmc_sec_title">Results</h3>
<p>Participants (median age: 30.5 years [IQR: 5.8]; 78% female; 89% Chinese; median 6.5 years of experience [IQR: 4.5]; four with prior HIV-related experience) showed a mean increase in knowledge scores of 14.2% (95% CI: 8.2%–20.1%; p &lt; 0.001), increasing from 64.7% to 78.9%. Scores for four mid-career participants (50% female, 5–10 years of experience, all with undergraduate degrees, including one with prior HIV-related training), however, did not improve, suggesting that tailored learning approaches may be needed, and that existing knowledge or prior experience do not necessarily predict learning outcomes. PrEP knowledge gaps remained primarily in counseling (−22%), identifying candidates (−12%), clinical contraindications (−6%), effectiveness (−6%), and management of missed doses for daily PrEP (−6%), highlighting potential challenges in clinical decision-making and patient communication. Most pharmacists agreed that the training was well-structured, easy to understand, of appropriate duration, and useful for their work. Satisfaction was high, as was willingness to recommend it.</p></section><section id="sec004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>The novel online self-paced training program improved pharmacists’ PrEP knowledge, though variability in knowledge gains suggests the need for enhancements. Incorporating case-based, problem-based, and simulation-based learning may improve comprehension, particularly in patient counseling, eligibility assessment, and PrEP contraindications.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">Introduction</h2>
<p>In Malaysia, the HIV epidemic remains concentrated in key populations such as men who have sex with men (MSM), people who inject drugs (PWID) and transgender women, each with elevated HIV prevalence of 12.9%, 7.5%, and 5.9%, respectively [<a href="#pone.0328713.ref001" class="usa-link" aria-describedby="pone.0328713.ref001">1</a>]. Despite national efforts, annual HIV infections continue to rise over the past decade, driven primarily by sexual transmission and hindered by suboptimal treatment and prevention coverage [<a href="#pone.0328713.ref002" class="usa-link" aria-describedby="pone.0328713.ref002">2</a>,<a href="#pone.0328713.ref003" class="usa-link" aria-describedby="pone.0328713.ref003">3</a>]. The shift from injection-related to sexual transmission underscores the urgent need to scale up HIV pre-exposure prophylaxis (PrEP), a proven biomedical intervention for preventing sexual HIV acquisition [<a href="#pone.0328713.ref003" class="usa-link" aria-describedby="pone.0328713.ref003">3</a>].</p>
<p>In a setting where same-sex behavior, drug use, and transgender identities are criminalized, however, conventional models of PrEP delivery face significant structural and societal barriers [<a href="#pone.0328713.ref004" class="usa-link" aria-describedby="pone.0328713.ref004">4</a>]. Following the World Health Organization (WHO)’s 2014 recommendation, Malaysia incorporated PrEP into its National Strategic Plan (NSP) and antiretroviral therapy consensus guidelines in 2018 [<a href="#pone.0328713.ref005" class="usa-link" aria-describedby="pone.0328713.ref005">5</a>,<a href="#pone.0328713.ref006" class="usa-link" aria-describedby="pone.0328713.ref006">6</a>]. Yet, access to PrEP remains limited, primarily restricted to selected private clinics and university hospitals within the Klang Valley [<a href="#pone.0328713.ref007" class="usa-link" aria-describedby="pone.0328713.ref007">7</a>], and only recently, since January 2023, has it become available in 31 government-run primary care clinics nationwide [<a href="#pone.0328713.ref003" class="usa-link" aria-describedby="pone.0328713.ref003">3</a>].</p>
<p>With an estimated 220,000 MSM who could benefit from PrEP in Malaysia [<a href="#pone.0328713.ref008" class="usa-link" aria-describedby="pone.0328713.ref008">8</a>,<a href="#pone.0328713.ref009" class="usa-link" aria-describedby="pone.0328713.ref009">9</a>], current service delivery models have reached fewer than 5,000 individuals [<a href="#pone.0328713.ref003" class="usa-link" aria-describedby="pone.0328713.ref003">3</a>], highlighting the need for alternative, differentiated service delivery models beyond traditional medical facilities to expand PrEP access. The WHO recommends tailoring PrEP services to the needs and preferences of key populations to improve uptake, adherence, and overall effectiveness [<a href="#pone.0328713.ref010" class="usa-link" aria-describedby="pone.0328713.ref010">10</a>]. Community pharmacies offer a promising and innovative opportunity for expanding PrEP access through reduced stigma reinforcement and low-barrier service delivery. In Malaysia, over 3,000 community pharmacies operate with extended hours and frequent public interactions, averaging 31 visits per adult annually [<a href="#pone.0328713.ref011" class="usa-link" aria-describedby="pone.0328713.ref011">11</a>,<a href="#pone.0328713.ref012" class="usa-link" aria-describedby="pone.0328713.ref012">12</a>].</p>
<p>A qualitative study observed that MSM in Malaysia preferred PrEP delivery in pharmacies over current venues [<a href="#pone.0328713.ref013" class="usa-link" aria-describedby="pone.0328713.ref013">13</a>]. Furthermore, community pharmacists are well-trained healthcare professionals and well-positioned to provide PrEP service through strategic task-shifting, which involves the appropriate reallocation of responsibilities such as counselling and dispensing from physicians to pharmacists to improve service delivery and access. Globally, pharmacy-led PrEP models have been successfully implemented in settings like the United States and Kenya, with evidence supporting their feasibility and acceptability [<a href="#pone.0328713.ref014" class="usa-link" aria-describedby="pone.0328713.ref014">14</a>–<a href="#pone.0328713.ref018" class="usa-link" aria-describedby="pone.0328713.ref018">18</a>]. In Malaysia, such services remain unavailable, despite their potential to overcome barriers associated with public healthcare facilities, including stigma, overcrowding, long wait times, and limited focus on preventive care [<a href="#pone.0328713.ref018" class="usa-link" aria-describedby="pone.0328713.ref018">18</a>]. One of the main barriers to implementing PrEP services in pharmacies, however, is the lack of pharmacist training [<a href="#pone.0328713.ref019" class="usa-link" aria-describedby="pone.0328713.ref019">19</a>–<a href="#pone.0328713.ref021" class="usa-link" aria-describedby="pone.0328713.ref021">21</a>], as pharmacists in the public or private sector have been minimally exposed to this effective treatment. Studies consistently report low levels of PrEP knowledge among pharmacists [<a href="#pone.0328713.ref019" class="usa-link" aria-describedby="pone.0328713.ref019">19</a>,<a href="#pone.0328713.ref022" class="usa-link" aria-describedby="pone.0328713.ref022">22</a>–<a href="#pone.0328713.ref024" class="usa-link" aria-describedby="pone.0328713.ref024">24</a>], and preferences for receiving training through online platforms [<a href="#pone.0328713.ref025" class="usa-link" aria-describedby="pone.0328713.ref025">25</a>]. Although training and education are critical strategies for implementing evidence-based practices (EBPs), pharmacist-specific PrEP education has not yet been developed or tested.</p>
<p>To address this implementation gap, our study developed and evaluated an online training module tailored for Malaysian community pharmacists to prepare them for tenofovir-based oral PrEP service delivery. This training was intended to equip pharmacists with the necessary knowledge and confidence to conduct PrEP assessments and initiate telemedicine-enabled prescriptions in a future pharmacy-led PrEP model. Adequate training is essential for the successful implementation of future pharmacy-led PrEP services, as sufficient PrEP knowledge enhances pharmacists’ dispensing practices and counseling confidence [<a href="#pone.0328713.ref024" class="usa-link" aria-describedby="pone.0328713.ref024">24</a>,<a href="#pone.0328713.ref026" class="usa-link" aria-describedby="pone.0328713.ref026">26</a>]. While the Malaysian Society for HIV Medicine (MASHM) has developed a self-paced online course on PrEP and post-exposure prophylaxis (PEP) for general practitioners [<a href="#pone.0328713.ref027" class="usa-link" aria-describedby="pone.0328713.ref027">27</a>], there are currently no equivalent modules tailored for pharmacists. Our newly created training strategy fills this gap by focusing on the unique roles and responsibilities of pharmacists in providing PrEP within the community pharmacy setting.</p></section><section id="sec006"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec007"><h3 class="pmc_sec_title">Study design</h3>
<p>This pre-implementation study was guided by the Exploration-Preparation-Implementation-Sustainment (EPIS) framework, focusing on the Preparation phase [<a href="#pone.0328713.ref028" class="usa-link" aria-describedby="pone.0328713.ref028">28</a>]. It involved the development (May 2023) and delivery (June 2023) of an online, asynchronous, self-paced PrEP training program for community pharmacists in the Klang Valley. Before developing the training module, a stakeholder consultation was conducted in April 2023 to identify training needs and pharmacist competencies, and to select six private community pharmacies as study sites for future PrEP service implementation. The stakeholder consultation meeting involved 31 participants, including representatives from community pharmacies, professional societies, non-governmental organizations (NGOs), telemedicine providers, and HIV researchers.</p>
<p>Key training needs identified by stakeholders included foundational knowledge on HIV and PrEP, PrEP eligibility and continuation criteria, and risk behavior assessment. Stakeholders also emphasized essential competencies such as person-centered communication, professional conduct, and the ability to manage client confidentiality and address stigma-related concerns. To address these different domains, knowledge-based content was delivered through online self-paced training, which is the primary focus of this manuscript. Communication skills, professional behavior, and scenario-based role-playing sessions were covered in a supplementary in-person training workshop conducted after the completion of the online component. This workshop also included guidance on effective communication, emotional support, encouraging confirmatory testing, and collaboration with physicians and NGOs for participant follow-up and seamless referral to care.</p></section><section id="sec008"><h3 class="pmc_sec_title">Training program development</h3>
<p>A PrEP training committee comprising five experts—two from the MASHM, one from the Malaysian Pharmacists Society (MPS), and two academics—oversaw the training development. The online training program covered the fundamentals of PrEP which included efficacy, safety, eligibility criteria, initial assessment, HIV testing and other baseline tests, prescribing PrEP, and handling special situations. The core content was adapted from the HIV Connect online self-paced PrEP course for general practitioners, based on current guidelines and tailored to the identified needs of community pharmacists [<a href="#pone.0328713.ref010" class="usa-link" aria-describedby="pone.0328713.ref010">10</a>,<a href="#pone.0328713.ref027" class="usa-link" aria-describedby="pone.0328713.ref027">27</a>,<a href="#pone.0328713.ref029" class="usa-link" aria-describedby="pone.0328713.ref029">29</a>].</p>
<p>A few modifications were made to align the training with pharmacists’ scope of practice and enhance implementation readiness. The simplified content focused on oral PrEP with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as no other PrEP options were available or approved in Malaysia (e.g., tenofovir alafenamide/emtricitabine (TAF/FTC), long-acting injectable cabotegravir, and the dapivirine ring). A summary of special circumstances was added to aid comprehension. Additionally, brief implementation-focused modules were developed and incorporated to provide practical guidance on key aspects of the pharmacy-led PrEP service, including checklists for PrEP initiation and follow-up, adherence assessment and counselling, and referral pathways (when and who to refer) – each of which was to simplify implementation.</p>
<p>The final training program included 12 didactic videos (total duration: 1 hour 30 minutes), divided into PrEP-related content (63 minutes) and pharmacy-led service delivery (27 minutes) (<a href="#pone.0328713.t001" class="usa-link">Table 1</a>). Videos were prepared using narrated PowerPoint slides, similar to the preparation method of HIV Connect training videos. Additional resources were provided via online access to a Google Drive folder containing local and international PrEP-related guidelines as well as information about HIV prevalence in Malaysia, HIV testing, PEP, sexually transmitted infections (STI), sexual history taking, and Sexual Orientation, Gender Identity, and Expression (SOGIE).</p>
<section class="tw xbox font-sm" id="pone.0328713.t001"><h4 class="obj_head">Table 1.  Online PrEP training modules for community pharmacists and average time participants spent to complete each module.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">No.</th>
<th align="left" rowspan="1" colspan="1">Topics</th>
<th align="left" rowspan="1" colspan="1">Subtopics</th>
<th align="left" rowspan="1" colspan="1">Average time spent on each module (minutes: seconds)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">1.</td>
<td align="left" rowspan="8" colspan="1">PrEP</td>
<td align="left" rowspan="1" colspan="1">Introduction and indications</td>
<td align="left" rowspan="1" colspan="1">5:26</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2.</td>
<td align="left" rowspan="1" colspan="1">PrEP options</td>
<td align="left" rowspan="1" colspan="1">12:44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">3.</td>
<td align="left" rowspan="1" colspan="1">PrEP regimens</td>
<td align="left" rowspan="1" colspan="1">7:06</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">4.</td>
<td align="left" rowspan="1" colspan="1">Counselling</td>
<td align="left" rowspan="1" colspan="1">9:08</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">5.</td>
<td align="left" rowspan="1" colspan="1">Testing</td>
<td align="left" rowspan="1" colspan="1">13:00</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">6.</td>
<td align="left" rowspan="1" colspan="1">Same-day PrEP</td>
<td align="left" rowspan="1" colspan="1">4:18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">7.</td>
<td align="left" rowspan="1" colspan="1">Monitoring PrEP</td>
<td align="left" rowspan="1" colspan="1">3:14</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">8.</td>
<td align="left" rowspan="1" colspan="1">Special situations</td>
<td align="left" rowspan="1" colspan="1">8:56</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">9.</td>
<td align="left" rowspan="4" colspan="1">Implementation of pharmacy-led PrEP service</td>
<td align="left" rowspan="1" colspan="1">Project overview</td>
<td align="left" rowspan="1" colspan="1">6:57</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10.</td>
<td align="left" rowspan="1" colspan="1">Workflow</td>
<td align="left" rowspan="1" colspan="1">7:25</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">11.</td>
<td align="left" rowspan="1" colspan="1">PrEP assessment tool</td>
<td align="left" rowspan="1" colspan="1">7:30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">12.</td>
<td align="left" rowspan="1" colspan="1">Frequently asked questions</td>
<td align="left" rowspan="1" colspan="1">6:02</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0328713.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec009"><h3 class="pmc_sec_title">Participant recruitment</h3>
<p>Participants were recruited using purposive sampling from 29 May to 4 June 2023. A total of 20 community pharmacists were initially invited to participate: 15 from the six designated implementation sites and five registered members of the MPS. Participation was voluntary, and no financial incentives were provided. Of the 20 invited, two pharmacists withdrew due to work commitments, resulting in 18 pharmacists who completed the training and evaluation components of the study.</p></section><section id="sec010"><h3 class="pmc_sec_title">Training delivery</h3>
<p>A single-arm quasi-experimental pre-post study was conducted. The training was delivered through Edpuzzle (<a href="https://edpuzzle.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://edpuzzle.com</a>), an interactive learning platform that supports progress tracking, self-paced learning, and user engagement [<a href="#pone.0328713.ref030" class="usa-link" aria-describedby="pone.0328713.ref030">30</a>]. This platform was chosen for its free access, user-friendliness and ability to ensure module completion. Participants were given two weeks to complete the training.</p></section><section id="sec011"><h3 class="pmc_sec_title">Evaluation</h3>
<p>The effectiveness of the training program was evaluated using pre- and post-training knowledge tests (<a href="#pone.0328713.s001" class="usa-link">S1 File</a>), followed by a post-training feedback form (<a href="#pone.0328713.s002" class="usa-link">S2 File</a>). The knowledge test items were developed based on contents of the training modules and published literature [<a href="#pone.0328713.ref023" class="usa-link" aria-describedby="pone.0328713.ref023">23</a>,<a href="#pone.0328713.ref025" class="usa-link" aria-describedby="pone.0328713.ref025">25</a>,<a href="#pone.0328713.ref026" class="usa-link" aria-describedby="pone.0328713.ref026">26</a>]. The training committee also incorporated the training needs and core competencies identified during the stakeholder consultation, such as adequate knowledge of HIV, and eligibility criteria for PrEP initiation and continuation.</p>
<p>The knowledge assessment consisted of 20 multiple-choice questions covering key topics, including the definition and indication of PrEP, HIV transmission, medication used for PrEP, PrEP candidacy, PrEP effectiveness and time to protection, side effects and duration of use, HIV testing and additional tests, follow-up schedules, eligibility and dosing regimen for event-driven PrEP, risk factors for kidney toxicity, counselling points, adherence, and reasons for stopping PrEP. Each correct answer was awarded five points, resulting in a maximum score of 100 points. The same set of questions was used for both pre- and post-tests to measure gain using identical items. The tests were pre-tested with five pharmacists not involved in the study to assess the clarity, comprehensibility, and appropriateness. Revisions were made based on their feedback, and the final version was reviewed and approved by the training committee.</p>
<p>The post-training feedback form consisted of four sections. The first section assessed key aspects of the training program, including content coverage, organization, clarity, duration, usefulness of additional resources, overall satisfaction, perceived relevance to professional practice, and likelihood of recommending the training to others. Participants rated their agreement using a five-point Likert scale, ranging from “strongly disagree” to “strongly agree”. Sections two to four included open-ended questions to identify the most useful or valuable aspects of the training program, gather suggestions for improvement, and invite any additional comments or questions.</p>
<p>Participants accessed the training via a personalized Edpuzzle link after completing the pre-training knowledge test and demographic survey. After completing the training modules, participants completed the post-training knowledge test. They were then invited to fill out an anonymous feedback form, which was optional. All assessments and forms were administered using Google Forms, with responses automatically compiled in Google Sheets.</p></section><section id="sec012"><h3 class="pmc_sec_title">Data analysis</h3>
<p>For knowledge assessment, demographic information and pre- and post-training knowledge scores were retrieved from Google Sheets and tabulated using Microsoft Excel. Descriptive and statistical analyses were performed using SPSS version 27.0. Paired t-tests assessed differences between pre- and post-training knowledge scores. Independent t-tests compared mean knowledge score differences by age (26–31 vs. 32–54 years), gender (male vs. female), education level (undergraduate vs. postgraduate), and prior HIV-related training (yes vs. no). One-way ANOVA examined mean knowledge score differences across ethnicity and years of experience. Statistical significance was set at p &lt; 0.05.</p>
<p>We used an 80% correct-response threshold, which is commonly employed in assessments of clinical knowledge for pharmacists and other healthcare professionals. This benchmark is often used to ensure a high level of competency in critical areas of practice. Many pharmacy education and certification programs set an 80% passing score to certify competency. For instance, the American Society of Health-System Pharmacists (ASHP) requires a minimum score of 80% on post-assessments for its Clinical Pharmacy Basics Certificate and Research Skills Certificate programs. The Association of Clinical Research Professionals (ACRP) mandates an 80% pass rate on its Clinical Research Knowledge Assessment (CRKA) to endorse foundational competencies in clinical research ACRP, and in educational settings, an 80% threshold is often used to determine competency. For example, a study on training student pharmacists in point-of-care testing required students to achieve at least 80% on knowledge examinations to be deemed competent [<a href="#pone.0328713.ref031" class="usa-link" aria-describedby="pone.0328713.ref031">31</a>]. Last, the 80% benchmark aligns with Bloom’s taxonomy, where scores above 80% indicate sufficient knowledge and positive attitudes in clinical practice assessments [<a href="#pone.0328713.ref032" class="usa-link" aria-describedby="pone.0328713.ref032">32</a>]. These examples illustrate that an 80% cutoff is a widely accepted standard to ensure that healthcare professionals possess the necessary knowledge to provide safe and effective care.</p>
<p>For post-training feedback, quantitative data from the Likert-scale responses were summarized using descriptive statistics. Open-ended responses from Sections 2–4 of the post-training feedback form were analyzed descriptively. Responses were grouped by common topics to identify recurring themes related to the most useful or valuable aspects of the training and suggestions for improvement. All unique responses were included, while overlapping or repetitive comments were excluded to avoid redundancy. Key insights were then summarized to support the interpretation of participant experiences and to inform future refinement of the training program.</p></section><section id="sec013"><h3 class="pmc_sec_title">Ethics and consent</h3>
<p>Ethical approval was obtained from the institutional review board at the University of Malaya Medical Centre-Medical Research Ethics Committee (UMMC-MREC) under the MREC ID: 20221026−11645. Participants were provided with a participation information sheet, and online written informed consent was obtained via Google Forms prior to study participation.</p></section></section><section id="sec014"><h2 class="pmc_sec_title">Results</h2>
<section id="sec015"><h3 class="pmc_sec_title">Participant characteristics</h3>
<p>The median age of the 18 community pharmacists was 30.5 years (IQR: 5.8). Most participants were female (77.8%), of Chinese ethnicity (89.0%), and held undergraduate degrees (89.0%). The median duration of work experience was 6.5 years (IQR: 4.5; range: 2–29 years). Only 22.2% reported prior HIV-related training or experience. Of these four participants, two had worked at a Ministry of Health (MOH) antiretroviral therapy (ART) clinic, one had completed a clinical attachment there, and one had worked with a non-governmental organization providing HIV care. On average, participants took 1 hour and 47 minutes to complete all training modules. Participant characteristics are detailed in <a href="#pone.0328713.t002" class="usa-link">Table 2</a>.</p>
<section class="tw xbox font-sm" id="pone.0328713.t002"><h4 class="obj_head">Table 2. Demographic and professional characteristics of participants (N = 18).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Participant characteristics</th>
<th align="left" rowspan="1" colspan="1">N (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Age (median (IQR): 30.5 (5.8) years)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Range</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> 26–31 years</td>
<td align="left" rowspan="1" colspan="1">10 (55.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> 32–54 years</td>
<td align="left" rowspan="1" colspan="1">8 (44.4%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gender</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Male</td>
<td align="left" rowspan="1" colspan="1">4 (22.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Female</td>
<td align="left" rowspan="1" colspan="1">14 (77.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chinese</td>
<td align="left" rowspan="1" colspan="1">16 (88.9%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Malay</td>
<td align="left" rowspan="1" colspan="1">1 (5.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Indian</td>
<td align="left" rowspan="1" colspan="1">1 (5.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Highest level of education</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Undergraduate degree</td>
<td align="left" rowspan="1" colspan="1">16 (88.9%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Postgraduate master’s degree</td>
<td align="left" rowspan="1" colspan="1">2 (11.1%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Years of experience (median (IQR): 6.5 (4.5) years)</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> ≤5 years</td>
<td align="left" rowspan="1" colspan="1">7 (38.9%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> 6–10 years</td>
<td align="left" rowspan="1" colspan="1">9 (50.0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> 11–15 years</td>
<td align="left" rowspan="1" colspan="1">1 (5.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> 16–20 years</td>
<td align="left" rowspan="1" colspan="1">0 (0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> &gt;20 years</td>
<td align="left" rowspan="1" colspan="1">1 (5.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prior HIV-related experience</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Yes</td>
<td align="left" rowspan="1" colspan="1">4 (22.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> No</td>
<td align="left" rowspan="1" colspan="1">14 (77.8%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0328713.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec016"><h3 class="pmc_sec_title">Pre- and post-training knowledge scores</h3>
<p>Mean knowledge scores increased significantly from 64.7% pre-training to 78.9% post-training (mean difference: 14.2%; 95% CI: 8.2–20.1%; p &lt; 0.001, paired t-test) (<a href="#pone.0328713.t003" class="usa-link">Table 3</a>). Although most participants showed improvement, four did not, with either no change or a decline in scores. These individuals shared similar characteristics—Chinese ethnicity, an undergraduate degree, and 5–10 years of experience—suggesting that mid-career pharmacists may require more tailored or interactive learning strategies. Interestingly, one of these participants had prior HIV-related experience, indicating that baseline familiarity does not necessarily predict knowledge gains in self-paced online learning.</p>
<section class="tw xbox font-sm" id="pone.0328713.t003"><h4 class="obj_head">Table 3. Participant-level pre- and post-test scores (N = 18).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Participant number</th>
<th align="left" rowspan="1" colspan="1">Pre-Test Score</th>
<th align="left" rowspan="1" colspan="1">Post-Test Score</th>
<th align="left" rowspan="1" colspan="1">Change in Score</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">−5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">+10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td align="left" rowspan="1" colspan="1">+25</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">45</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">+35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">85</td>
<td align="left" rowspan="1" colspan="1">+30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td align="left" rowspan="1" colspan="1">+10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">+10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">+10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">+10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">+15</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">85</td>
<td align="left" rowspan="1" colspan="1">+20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td align="left" rowspan="1" colspan="1">+20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">−5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">+20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">80</td>
<td align="left" rowspan="1" colspan="1">+30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">65</td>
<td align="left" rowspan="1" colspan="1">85</td>
<td align="left" rowspan="1" colspan="1">+20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mean score (standard deviation, SD)</td>
<td align="left" rowspan="1" colspan="1">
<strong>64.7 (9.8)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>78.8 (7.9)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lowest score<br>Highest score</td>
<td align="left" rowspan="1" colspan="1">
<strong>45</strong>
<br>
<strong>80</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>60</strong>
<br>
<strong>90</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mean difference (95% confidence interval, CI)</td>
<td align="left" rowspan="1" colspan="1">
<strong>+14.2 (8.2</strong>–<strong>20.1)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Percentage change</td>
<td align="left" rowspan="1" colspan="1">
<strong>+21.9%</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Paired t-test</td>
<td align="left" rowspan="1" colspan="1">
<strong>p &lt; 0.001</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>–</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0328713.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Statistical analysis revealed no significant differences in knowledge improvement by age (p = 0.302), gender (p = 0.594), ethnicity (p = 0.785), education level (p = 0.308), prior HIV-related training (p = 0.444), or years of experience (p = 0.897), suggesting the training was broadly effective across demographic groups. The observed variation in individual learning outcomes, particularly among those with similar professional profiles who did not improve, underscores the importance of offering complementary learning approaches that accommodate diverse learning styles and backgrounds.</p>
<p>Despite overall gains, analysis of individual test items revealed persistent knowledge gaps (<a href="#pone.0328713.t004" class="usa-link">Table 4</a>). No improvement was observed in responses related to indications for PrEP or its side effects. Declines were noted in several areas, including contraindications (–6%), effectiveness (–6%), management of missed doses (–6%), identification of PrEP candidates (–12%), and counseling points (–22%). These findings suggest confusion or insufficient understanding in clinical decision-making and patient communication, which are critical areas for safe and effective PrEP delivery.</p>
<section class="tw xbox font-sm" id="pone.0328713.t004"><h4 class="obj_head">Table 4. Percentage of correct responses by question number for pre- and post-training knowledge tests.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Question number</th>
<th align="left" rowspan="1" colspan="1">Aspect of assessment</th>
<th align="left" rowspan="1" colspan="1">Percentage of correct responses for pre-training (%)</th>
<th align="left" rowspan="1" colspan="1">Percentage of<br>correct responses<br>for post-training (%)</th>
<th align="left" rowspan="1" colspan="1">Change in correct responses (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">1.</td>
<td align="left" rowspan="1" colspan="1">Definition of PrEP</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">+33</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">Indications for PrEP</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">3.</td>
<td align="left" rowspan="1" colspan="1">Medication used for PrEP</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">+28</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">4.</td>
<td align="left" rowspan="1" colspan="1">PrEP use in pregnancy and breastfeeding; preventive effects and duration of PrEP use</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">+6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">5.</td>
<td align="left" rowspan="1" colspan="1">Contraindications for PrEP</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">−6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">6.</td>
<td align="left" rowspan="1" colspan="1">Effectiveness of PrEP</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">−6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">7.</td>
<td align="left" rowspan="1" colspan="1">Time-to-protection for cisgender women, transgender women on estradiol-based hormones and PWID who are on daily PrEP</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">+44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">8.</td>
<td align="left" rowspan="1" colspan="1">Side effects of PrEP</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">9.</td>
<td align="left" rowspan="1" colspan="1">Duration of PrEP use</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">+34</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10.</td>
<td align="left" rowspan="1" colspan="1">Additional tests before starting PrEP</td>
<td align="left" rowspan="1" colspan="1">78</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">+11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">11.</td>
<td align="left" rowspan="1" colspan="1">Recommended follow-up schedule</td>
<td align="left" rowspan="1" colspan="1">67</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">+27</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">12.</td>
<td align="left" rowspan="1" colspan="1">Frequency of HIV testing</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">67</td>
<td align="left" rowspan="1" colspan="1">+39</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">13.</td>
<td align="left" rowspan="1" colspan="1">Suitable candidates for event-driven PrEP</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">+44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">14.</td>
<td align="left" rowspan="1" colspan="1">Dosing regimen for event-driven PrEP</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">+44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">15.</td>
<td align="left" rowspan="1" colspan="1">Risk factors of renal toxicity in PrEP users</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">28</td>
<td align="left" rowspan="1" colspan="1">+11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">16.</td>
<td align="left" rowspan="1" colspan="1">Counselling key points</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">−22</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">17.</td>
<td align="left" rowspan="1" colspan="1">PrEP adherence counselling</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">+5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">18.</td>
<td align="left" rowspan="1" colspan="1">Management of missed doses for daily PrEP</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">−6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">19.</td>
<td align="left" rowspan="1" colspan="1">Reasons for stopping PrEP</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">+6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">20.</td>
<td align="left" rowspan="1" colspan="1">Identifying PrEP candidates</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">−12</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">
<strong>Mean percentage of correct responses (SD)</strong>
</td>
<td align="left" rowspan="1" colspan="1">64.7 (23.7)</td>
<td align="left" rowspan="1" colspan="1">78.8 (20.8)</td>
<td align="left" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">
<strong>Mean difference in percentage of correct responses (95% CI)</strong>
</td>
<td align="left" colspan="2" rowspan="1">14.0 (4.3–23.8)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0328713.t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Conversely, significant gains were observed in topics initially had low baseline scores, such as time-to-protection for specific populations (+44%), eligibility for event-driven PrEP and its dosing regimen (+44% each), and HIV testing frequency (+39%). These improvements suggest the training was effective in addressing gaps in foundational knowledge. However, improvements in adherence counselling, assessment of renal toxicity risk factors, and additional tests required before initiating PrEP were modest (+5% to +11%), indicating that these topics may benefit from greater emphasis or the inclusion of more active learning strategies.</p>
<p>Overall, while the training improved general knowledge among participants, it did not sufficiently address all key knowledge deficits, particularly in areas related to clinical decision-making, patient assessment, and counseling. These findings suggest that community pharmacists may require more detailed explanations and enhanced instructional methods to improve comprehension in these critical domains. As such, certain content areas may benefit from more structured or interactive delivery formats, such as case-based learning and real-world clinical scenarios. Augmenting the online modules with these approaches may better equip pharmacists with the practical knowledge and skills necessary for effective PrEP service delivery.</p></section><section id="sec017"><h3 class="pmc_sec_title">Participant feedback</h3>
<p>Of the 18 participants, 13 provided anonymous feedback (<a href="#pone.0328713.t005" class="usa-link">Table 5</a>). Most respondents agreed or strongly agreed that the training was relevant, well-organized, easy to follow and understand, of appropriate duration, and useful for their professional work. Overall satisfaction with the training was high, with all participants indicating they would recommend it to others. However, despite this positive perception, the findings suggest a disconnect between participants’ perceived learning and their actual knowledge gains, indicating that some may have overestimated their understanding of the material.</p>
<section class="tw xbox font-sm" id="pone.0328713.t005"><h4 class="obj_head">Table 5.  Participant feedback regarding online training program (N = 13).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Provided statement</th>
<th align="left" rowspan="1" colspan="1">Strongly disagree</th>
<th align="left" rowspan="1" colspan="1">Disagree</th>
<th align="left" rowspan="1" colspan="1">Neither agree nor disagree</th>
<th align="left" rowspan="1" colspan="1">Agree</th>
<th align="left" rowspan="1" colspan="1">Strongly agree</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">The training covered the content I expected.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">8 (62%)</td>
<td align="left" rowspan="1" colspan="1">5 (38%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">The content was organized and easy to follow.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">8 (62%)</td>
<td align="left" rowspan="1" colspan="1">5 (38%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">The content was easy to understand.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (8%)</td>
<td align="left" rowspan="1" colspan="1">3 (23%)</td>
<td align="left" rowspan="1" colspan="1">5 (38%)</td>
<td align="left" rowspan="1" colspan="1">4 (31%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">The duration of training was appropriate.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (8%)</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">The additional resources shared were helpful.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">2 (15%)</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
<td align="left" rowspan="1" colspan="1">5 (38%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Overall, I am satisfied with this training.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1 (8%)</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">This training will be useful for my work.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">7 (54%)</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">I would recommend this to others.</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">6 (46%)</td>
<td align="left" rowspan="1" colspan="1">7 (54%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0328713.t005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Regarding the most useful or valuable aspects of the training program, participants appreciated the short, asynchronous format of the modules and the clarity in presenting PrEP information—including indications, types of clients to expect, and dosing regimens. They also highlighted the inclusion of a FAQ section, the summary of the PrEP service delivery process, access to supplementary materials, and the ability to revisit the content at their own pace.</p>
<p>Despite these positive responses, several suggestions for improvement emerged from the feedback. One participant noted that the first eight modules were fast-paced and contained a high volume of clinical information, which could be overwhelming for those new to PrEP. This raised concerns about cognitive load and the need to better scaffold complex content for learners with varying levels of familiarity.</p>
<p>In terms of learning preferences, several participants expressed a desire for more interactive elements. They recommended incorporating short quizzes at the end of each video to reinforce understanding and offering an indexed layout of the training content for easier navigation and review. These suggestions reflect a broader preference for more active learning strategies to complement the self-paced format.</p>
<p>Participants also suggested improving clarity by adding an introductory slide to define key terms such as “cisgender,” “point-of-care testing (POCT),” and “injection drug users (IDU).” A few respondents recommended including a brief overview of PEP to guide pharmacists on when to refer clients to physicians, which would enhance their confidence in making appropriate clinical decisions. Importantly, some participants expressed uncertainty about managing PrEP for clients on estradiol or hormone therapy, as well as how to navigate conversations with transgender clients.</p>
<p>Notably, many of these feedback points reflect areas in which knowledge scores were lower or declined, such as counseling, identifying PrEP candidates, and understanding nuanced clinical content. This convergence between self-reported challenges and test performance highlights a need to enhance these components in future training iterations through more targeted content, inclusive language, and interactive learning strategies.</p></section></section><section id="sec018"><h2 class="pmc_sec_title">Discussion</h2>
<p>To prepare community pharmacists to competently provide a new service (i.e., PrEP), they must first be equipped with essential clinical knowledge. To our knowledge, this is the first study to adapt a physician-targeted PrEP training program for pharmacists and evaluate its effectiveness, demonstrating a significant improvement in knowledge scores (from 64.7% to 78.9%, p &lt; 0.001).</p>
<p>Several studies have assessed pharmacists’ PrEP knowledge, though none have included training followed by pre-and post-assessment. A study in Utah reported a mean PrEP knowledge score of 4.99 (SD 2.1) among 251 pharmacists, with scores ranging from 1 to 8 for correct responses [<a href="#pone.0328713.ref023" class="usa-link" aria-describedby="pone.0328713.ref023">23</a>]. Another study in Zimbabwe found that 58% of pharmacists (65/112) were knowledgeable about PrEP, scoring 9 or higher out of 15 questions [<a href="#pone.0328713.ref033" class="usa-link" aria-describedby="pone.0328713.ref033">33</a>]. Meanwhile, a study of among 194 U.S. pharmacy students reported a mean knowledge score of 78.8% [<a href="#pone.0328713.ref026" class="usa-link" aria-describedby="pone.0328713.ref026">26</a>]. Although these studies used different surveys and did not establish a standardized cut-off for PrEP competency, we used a benchmark of 80% for pharmacists who undergo structured PrEP training, common in e-learning modules.</p>
<p>This threshold is intended to reflect a level of knowledge above baseline levels observed among pharmacy students, and to approximate a level of readiness for providing PrEP-related services. However, we acknowledge that this threshold is not evidence-based and further research is needed to define and validate an appropriate competency standard for pharmacists involved in PrEP service delivery.</p>
<p>In this study, statistical analyses showed no significant differences in knowledge improvement by age, gender, ethnicity, education level, years of experience or prior HIV-related training or experience. This finding aligns with the study conducted in Zimbabwe, which reported no significant associations between PrEP knowledge and demographic factors, such as age, gender, years of practice, and pharmacy setting [<a href="#pone.0328713.ref033" class="usa-link" aria-describedby="pone.0328713.ref033">33</a>]. In contrast, the U.S. study found that cisgender MSM, bisexual participants, and White students had higher PrEP knowledge than their peers, and that late-phase students outperformed early-phase students [<a href="#pone.0328713.ref026" class="usa-link" aria-describedby="pone.0328713.ref026">26</a>]. Similarly, a study in Utah reported higher PrEP knowledge among pharmacists with PharmD degrees and fewer years of experience [<a href="#pone.0328713.ref023" class="usa-link" aria-describedby="pone.0328713.ref023">23</a>]. These differences may reflect contextual variations in education, training, or baseline familiarity with HIV prevention services, including PrEP, highlighting the potential of structured training programs to reduce disparities in knowledge across diverse pharmacist populations.</p>
<p>While the online training program was generally effective for most participants, as evidenced by overall improvement in knowledge scores, it did not produce the desired consistent knowledge gains across all participants. Four participants did not demonstrate any improvement, and no gains were observed in topics such as PrEP indications and side effects.</p>
<p>Certain knowledge gaps persisted despite training. While all participants identified the approved PrEP medication post-training, knowledge of HIV testing frequency improved from 28% to 67%; however, correct responses on contraindications declined from 78% to 72%. A study in New York found that only 38% of pharmacy students knew the recommended testing frequency and 28% recognized reduced creatinine clearance as a contraindication to prescribing tenofovir-based PrEP [<a href="#pone.0328713.ref025" class="usa-link" aria-describedby="pone.0328713.ref025">25</a>]. These findings suggest that applied clinical reasoning remains a challenge, even when foundational knowledge is covered.</p>
<p>Knowledge deficits also remained in key areas, such as effectiveness, counselling key points, management of missed doses, and identification of PrEP candidates. This indicates that while the training effectively conveyed foundational concepts, it was less successful in fostering applied clinical reasoning, which is an essential skill for assessing PrEP suitability and counseling diverse clients.</p>
<p>Participant feedback provided valuable insight into knowledge gaps. Several participants reported difficulties with the pacing and density of clinical content in the initial modules, which may have contributed to lower post-training performance in topics such as counseling, and identification of eligible clients. Suggestions to include introductory slides for key terms, overviews of related topics such as PEP, and clearer guidance on managing transgender clients aligned closely with the test items that showed decreased or modest gains. These reflections indicate that participants not only struggled with specific clinical knowledge but also required more support in applying that knowledge to real-world scenarios.</p>
<p>Participants also called for more interactive features, such as short quizzes after subtopics and indexed content. This aligns with evidence supporting test-enhanced learning, which improves retention and understanding [<a href="#pone.0328713.ref034" class="usa-link" aria-describedby="pone.0328713.ref034">34</a>,<a href="#pone.0328713.ref035" class="usa-link" aria-describedby="pone.0328713.ref035">35</a>]. Moreover, participants expressed uncertainty around managing PrEP for transgender clients and integrating PEP into counseling—areas directly reflected in lower-scoring test items. The convergence of knowledge gaps and qualitative feedback emphasizes the need for improved instruction on inclusive care, clinical decision-making, and patient communication.</p>
<p>The training program was intentionally designed as a self-paced, asynchronous online course to accommodate the time constraints and staffing challenges commonly encountered in community pharmacy settings. This flexible delivery format was well-received by participants, who appreciated the ability to engage with the material at their convenience without disrupting daily workflow. The self-directed nature of the program, however, may have inadvertently contributed to a gap between participants’ perceived learning and their actual knowledge acquisition.</p>
<p>This discrepancy aligns with findings from a systematic review on pharmacists’ engagement with e-learning platforms, which revealed a recurring pattern: although most users expressed high levels of satisfaction—highlighting advantages such as flexibility, user-friendliness, and relevance to practice—these subjective assessments did not consistently correlate with measurable improvements in knowledge, skill acquisition, or clinical performance [<a href="#pone.0328713.ref036" class="usa-link" aria-describedby="pone.0328713.ref036">36</a>]. While the review affirmed that e-learning can be just as effective as traditional face-to-face instruction for knowledge delivery, it also underscored a key limitation: when used in isolation, digital platforms often fall short in cultivating applied skills such as patient counseling, therapeutic decision-making, or inter-professional communication. These findings reinforce the importance of integrating e-learning with interactive elements—such as live discussions, case-based simulations, or hands-on workshops—to better translate theoretical knowledge into real-world clinical competence [<a href="#pone.0328713.ref036" class="usa-link" aria-describedby="pone.0328713.ref036">36</a>].</p>
<p>According to the Expert Recommendations for Implementing Change (ERIC) taxonomy and implementation science literature, while training and education are essential strategies, they are often insufficient on their own and should be supplemented with strategies, such as audit and feedback, educational outreach, and external facilitation to strengthen implementation [<a href="#pone.0328713.ref037" class="usa-link" aria-describedby="pone.0328713.ref037">37</a>,<a href="#pone.0328713.ref038" class="usa-link" aria-describedby="pone.0328713.ref038">38</a>]. Future efforts could incorporate follow-up strategies such as feedback on PrEP case assessments, interactive or tailored content, and regular check-ins or mentoring by program implementers, to help reinforce learning, particularly for mid-career pharmacists who may derive less benefit from conventional e-learning formats.</p>
<p>A systematic review in medical education found that modern learning techniques, such as case-based, problem-based, and simulation-based learning, were more effective than traditional didactic lectures in improving knowledge acquisition and learner engagement [<a href="#pone.0328713.ref039" class="usa-link" aria-describedby="pone.0328713.ref039">39</a>]. These approaches promote active learning, enhance clinical reasoning, support knowledge retention, and develop essential analytical and problem-solving skills [<a href="#pone.0328713.ref039" class="usa-link" aria-describedby="pone.0328713.ref039">39</a>].</p>
<p>A one-day in-person workshop was conducted two weeks after completion of the online modules as a reinforcement activity to clarify complex topics and strengthen pharmacists’ readiness for PrEP service delivery. All 18 pharmacists who completed the online training were invited to attend and 16 attended. The workshop was facilitated by a multidisciplinary team, including infectious disease physicians, academicians, and community health workers from NGOs, and was attended by a total of 35 participants, including pharmacists. It aimed to build practical skills through applied learning methods such as case-based discussions, interactive group activities, and role-playing exercises. Key topics included effective communication, stigma reduction, and appropriate referral pathways to clinical and community-based services. Role-playing sessions, facilitated by NGO representatives, were specifically designed to enhance pharmacists’ sensitivity to the needs of key populations. To further reinforce learning, we incorporated a review of knowledge assessment items, particularly those with lower post-training correct responses. These activities helped participants revisit key concepts, clarify misconceptions, and apply their knowledge to realistic scenarios.</p>
<p>To support real-world readiness and continued learning, we conducted a dry-run session prior to implementation, simulating client interactions to give pharmacists the opportunity to practice delivering the PrEP service as intended. Additionally, a WhatsApp group was created to enable real-time communication, feedback, and peer support throughout the implementation phase. Coordinated by the research team, this platform supported informal mentoring, addressed emerging questions, and facilitated continuous learning. These active learning strategies proved valuable in bridging theoretical knowledge with practice and demonstrated the potential of blended training models to support the scale-up of pharmacy-led PrEP services.</p>
<p>Current evidence shows that pharmacy-led PrEP services have been implemented or piloted in several countries, widely accepted by clients and pharmacy providers and shown to reach underserved populations, such as young men and minorities, thereby improving overall PrEP coverage [<a href="#pone.0328713.ref021" class="usa-link" aria-describedby="pone.0328713.ref021">21</a>,<a href="#pone.0328713.ref040" class="usa-link" aria-describedby="pone.0328713.ref040">40</a>]. With proper training and oversight, pharmacists can safely initiate and manage clients on PrEP, achieving initiation and continuation rates comparable to those of traditional clinics [<a href="#pone.0328713.ref040" class="usa-link" aria-describedby="pone.0328713.ref040">40</a>]. This presents an opportunity for community pharmacists in Malaysia to expand their role in public health and contribute to the national goal of achieving zero new infections outlined in the Malaysian NSP to End AIDS by 2030 [<a href="#pone.0328713.ref005" class="usa-link" aria-describedby="pone.0328713.ref005">5</a>]. The online training program could be a viable tool to support this initiative; however, improvements in instructional design, delivery format, and system-level integration are essential for sustained impact.</p>
<p>Scaling up the training program for wider implementation will also require addressing practical barriers such as internet access, digital literacy, and varying levels of baseline knowledge. Pharmacists in rural or underserved areas may face connectivity challenges or have limited prior exposure to HIV-related services, potentially affecting their learning outcomes. Downloadable modules, mobile-optimized platforms, and regionally organized in-person workshops could help bridge these gaps. Integrating pharmacists into the national PrEP service framework will require policy and regulatory support, including a formal certification pathway, endorsement of standardized training, and mechanisms for collaboration between pharmacists and HIV physicians via telemedicine platforms.</p>
<section id="sec019"><h3 class="pmc_sec_title">Strengths</h3>
<p>This is the first study in Malaysia, and among the first in the Asia-Pacific, to develop and evaluate a pharmacist-specific online PrEP training program. The training was informed by the EPIS implementation science framework, ensuring that contextual, structural, and practical considerations were integrated into its design. Unlike previous cross-sectional studies, we assessed knowledge improvement pre- and post-training. Additionally, incorporating participant feedback provided valuable insight into the learning experience and highlighted areas for improvement. Stakeholder consultation during training development ensured that the content was contextually relevant, feasible, and aligned with national HIV prevention priorities, enhancing the potential for scale-up and policy integration.</p></section><section id="sec020"><h3 class="pmc_sec_title">Limitations</h3>
<p>Despite the many important findings, there are limitations. First, the small, relatively homogenous sample may not accurately represent the broader population of Malaysian community pharmacists. Most participants were of Chinese ethnicity, held undergraduate degrees, and had about 8 years of experience. While the sample was representative of private community pharmacists in Malaysia [<a href="#pone.0328713.ref041" class="usa-link" aria-describedby="pone.0328713.ref041">41</a>], future studies should aim for broader representation. Second, participation was limited to pharmacists from study sites and MPS representatives in Klang Valley due to budget constraints. Findings here may not reflect community pharmacists in other regions of the country.</p>
<p>Third, knowledge was assessed immediately after the online training, but not after the in-person workshop. Since the workshop incorporated active learning strategies, an additional post-workshop assessment could have helped evaluate the added value of these components. While the workshop was not formally evaluated, the workshop served as a complementary component to support applied learning and readiness for pharmacy-led PrEP service delivery. Fourth, the knowledge test items used in this study were not validated through psychometric testing. Although they were developed based on training content and supported by published literature, the absence of formal validation may limit their reliability and comparability to other instruments.</p>
<p>Fifth, performance bias was possible. Participants were aware of the pre-post design and may have reviewed materials in advance. Also, the online testing format allowed for potential access to external resources despite instructions to complete the tests independently, which could inflate scores. Additionally, although the feedback forms were completed anonymously, social desirability bias may still have influenced participants’ responses, potentially leading to an overestimation of satisfaction or perceived usefulness of the training.</p>
<p>Sixth, we measured only short-term knowledge gains and long-term retention was not assessed. Other studies have shown improved knowledge retention after 30 days [<a href="#pone.0328713.ref042" class="usa-link" aria-describedby="pone.0328713.ref042">42</a>], suggesting that practical application over time may enhance retention and that follow-up assessments are important for evaluating long-term impact. Lastly, we did not assess participants’ confidence or counseling skills. While knowledge acquisition is a necessary foundation, it does not guarantee competence in delivering PrEP services. Future studies should evaluate communication skills, self-efficacy, and observed performance to better capture readiness for real-world service delivery.</p></section></section><section id="sec021"><h2 class="pmc_sec_title">Conclusions</h2>
<p>This novel online, self-paced PrEP training program, developed to prepare community pharmacists for the future implementation of pharmacy-led PrEP service delivery, effectively improved PrEP knowledge. However, variability in knowledge gains and persistent knowledge gaps, particularly in areas such as patient counseling, eligibility assessment, contraindications, effectiveness and management of missed doses, highlight the need for further refinement. Incorporating active learning strategies such as case-based, problem-based, and simulation-based learning within a blended training model may enhance comprehension and support the translation of theoretical knowledge into practical application, thereby strengthening clinical decision-making and counseling skills essential for confident and effective PrEP service delivery.</p>
<p>Future studies should involve larger and more diverse samples to enhance generalizability and statistical power, utilize validated knowledge assessment tools, and examine predictors of PrEP knowledge improvement. In addition, extended follow-up is warranted to evaluate sustained knowledge retention and its translation into real-world practice. Evaluating the added value of blended training components—such as in-person workshops, peer support mechanisms, and structured feedback—will also be important to understand their impact on pharmacist confidence, counseling performance, and readiness to deliver PrEP services effectively. Ultimately, this training represents a critical step toward integrating pharmacists into national PrEP service delivery models and advancing equitable access to HIV prevention in Malaysia.</p></section><section id="sec022"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0328713.s001"><div class="caption p">
<span>S1 File. Pre- and post-training knowledge test questionnaire.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s001.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s001.docx</a><sup> (19.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0328713.s002"><div class="caption p">
<span>S2 File. Post-training feedback form.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s002.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s002.docx</a><sup> (15.7KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We would like to thank all research participants for their commitment and willingness to participate in this study. We are grateful for the invaluable support from the Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), the Malaysian Society for HIV Medicine (MASHM), and the Malaysian Pharmacists Society (MPS) throughout the conduct of this study. We also wish to acknowledge the contribution of the research assistants involved in the preparation and execution of the online training, namely: Foo Xu Qing and Assif Shamim Mustaffa.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>The relevant data are available in the Harvard Dataverse at <a href="https://doi.org/10.7910/DVN/BONKBK" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.7910/DVN/BONKBK</a>.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This research was funded by the Malaysian Implementation Science Training program (MIST) for YG supported by Fogarty International Center, NIDA, NIMH and NICHD (D43 TW-011324 – PI: Frederick L. Altice, Adeeba Kamarulzaman) <a href="https://www.fic.nih.gov/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fic.nih.gov/</a> and the World Health Organization (WHO) (WHO registration: 2023/1363112-0) for IA <a href="https://www.who.int/malaysia" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.who.int/malaysia</a>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0328713.ref001">
<span class="label">1.</span><cite>Ministry of Health Malaysia. Integrated Biological and Behavioural Surveillance (IBBS) Survey 2022. Putrajaya: Ministry of Health Malaysia; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Integrated%20Biological%20and%20Behavioural%20Surveillance%20(IBBS)%20Survey%202022&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref002">
<span class="label">2.</span><cite>Nachega JB, Musoke P, Kilmarx PH, Gandhi M, Grinsztejn B, Pozniak A, et al. Global HIV control: is the glass half empty or half full?. Lancet HIV. 2023;10(9):e617–22. doi: 10.1016/S2352-3018(23)00150-9

</cite> [<a href="https://doi.org/10.1016/S2352-3018(23)00150-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10733629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37506723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Global%20HIV%20control:%20is%20the%20glass%20half%20empty%20or%20half%20full?&amp;author=JB%20Nachega&amp;author=P%20Musoke&amp;author=PH%20Kilmarx&amp;author=M%20Gandhi&amp;author=B%20Grinsztejn&amp;volume=10&amp;issue=9&amp;publication_year=2023&amp;pmid=37506723&amp;doi=10.1016/S2352-3018(23)00150-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref003">
<span class="label">3.</span><cite>Ministry of Health Malaysia. 2024 Global AIDS Monitoring: Country Progress Report - Malaysia. Putrajaya: Ministry of Health Malaysia; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=2024%20Global%20AIDS%20Monitoring:%20Country%20Progress%20Report%20-%20Malaysia&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref004">
<span class="label">4.</span><cite>Joint United Nations Programme on HIV/AIDS (UNAIDS). In danger: UNAIDS global AIDS update 2022. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS);
2022.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12349391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=In%20danger:%20UNAIDS%20global%20AIDS%20update%202022&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref005">
<span class="label">5.</span><cite>Ministry of Health Malaysia. National Strategic Plan: Ending AIDS 2016–2030. Putrajaya: Ministry of Health Malaysia;
2015.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=National%20Strategic%20Plan:%20Ending%20AIDS%202016%E2%80%932030&amp;publication_year=2015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref006">
<span class="label">6.</span><cite>World Health Organization (WHO). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2016.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27559558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Consolidated%20guidelines%20on%20HIV%20prevention,%20diagnosis,%20treatment%20and%20care%20for%20key%20populations&amp;publication_year=2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref007">
<span class="label">7.</span><cite>Chong ML, Galka J, Noh RM, Azwa RISR. My PrEP Locator: PrEP directory in Malaysia. Int J Infect Dis. 2020;101:204–5.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Infect%20Dis&amp;title=My%20PrEP%20Locator:%20PrEP%20directory%20in%20Malaysia&amp;author=ML%20Chong&amp;author=J%20Galka&amp;author=RM%20Noh&amp;author=RISR%20Azwa&amp;volume=101&amp;publication_year=2020&amp;pages=204-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref008">
<span class="label">8.</span><cite>Dubov A, Altice FL, Gutierrez JI, Wickersham JA, Azwa I, Kamarulzaman A, et al. Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment. Sci Rep. 2023;13(1):14200. doi: 10.1038/s41598-023-41264-5

</cite> [<a href="https://doi.org/10.1038/s41598-023-41264-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10468492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37648731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Pre-exposure%20prophylaxis%20service%20among%20men%20who%20have%20sex%20with%20men%20in%20Malaysia:%20findings%20from%20a%20discrete%20choice%20experiment&amp;author=A%20Dubov&amp;author=FL%20Altice&amp;author=JI%20Gutierrez&amp;author=JA%20Wickersham&amp;author=I%20Azwa&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=14200&amp;pmid=37648731&amp;doi=10.1038/s41598-023-41264-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref009">
<span class="label">9.</span><cite>Ministry of Health Malaysia. Size Estimation of Key Populations in Malaysia 2018. Putrajaya: Ministry of Health Malaysia;
2018.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Size%20Estimation%20of%20Key%20Populations%20in%20Malaysia%202018&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref010">
<span class="label">10.</span><cite>World Health Organization (WHO). Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance. Technical Brief. Geneva: World Health Organization (WHO); 2022.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Differentiated%20and%20simplified%20pre-exposure%20prophylaxis%20for%20HIV%20prevention:%20update%20to%20WHO%20implementation%20guidance.%20Technical%20Brief&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref011">
<span class="label">11.</span><cite>Hamidi N, Tan YR, Jawahir S, Tan EH. Determinants of community pharmacy utilisation among the adult population in Malaysia: findings from the National Health and Morbidity Survey 2019. BMC Health Serv Res. 2021;21(1):649. doi: 10.1186/s12913-021-06656-1

</cite> [<a href="https://doi.org/10.1186/s12913-021-06656-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8254968/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34217293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Health%20Serv%20Res&amp;title=Determinants%20of%20community%20pharmacy%20utilisation%20among%20the%20adult%20population%20in%20Malaysia:%20findings%20from%20the%20National%20Health%20and%20Morbidity%20Survey%202019&amp;author=N%20Hamidi&amp;author=YR%20Tan&amp;author=S%20Jawahir&amp;author=EH%20Tan&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pages=649&amp;pmid=34217293&amp;doi=10.1186/s12913-021-06656-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref012">
<span class="label">12.</span><cite>Tew MM, Hatah E, Arif F, Abdul Wahid MA, Makmor-Bakry M, Abdul Maulad KN. Geospatial analysis of distribution of community pharmacies and other health care facilities providing minor ailments services in Malaysia. J Pharm Policy Practice. 2021;14:1–11.</cite> [<a href="https://doi.org/10.1186/s40545-021-00308-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7903721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33627199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharm%20Policy%20Practice&amp;title=Geospatial%20analysis%20of%20distribution%20of%20community%20pharmacies%20and%20other%20health%20care%20facilities%20providing%20minor%20ailments%20services%20in%20Malaysia&amp;author=MM%20Tew&amp;author=E%20Hatah&amp;author=F%20Arif&amp;author=MA%20Abdul%20Wahid&amp;author=M%20Makmor-Bakry&amp;volume=14&amp;publication_year=2021&amp;pages=1-11&amp;pmid=33627199&amp;doi=10.1186/s40545-021-00308-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref013">
<span class="label">13.</span><cite>Bourne A, Cassolato M, Thuan Wei CK, Wang B, Pang J, Lim SH, et al. Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: findings from a qualitative study. J Int AIDS Soc. 2017;20(1):21899. doi: 10.7448/IAS.20.1.21899

</cite> [<a href="https://doi.org/10.7448/IAS.20.1.21899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5577697/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28782336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Int%20AIDS%20Soc&amp;title=Willingness%20to%20use%20pre-exposure%20prophylaxis%20(PrEP)%20for%20HIV%20prevention%20among%20men%20who%20have%20sex%20with%20men%20(MSM)%20in%20Malaysia:%20findings%20from%20a%20qualitative%20study&amp;author=A%20Bourne&amp;author=M%20Cassolato&amp;author=CK%20Thuan%20Wei&amp;author=B%20Wang&amp;author=J%20Pang&amp;volume=20&amp;issue=1&amp;publication_year=2017&amp;pages=21899&amp;pmid=28782336&amp;doi=10.7448/IAS.20.1.21899&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref014">
<span class="label">14.</span><cite>Tung EL, Thomas A, Eichner A, Shalit P. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care. Sex Health. 2018;15(6):556–61. doi: 10.1071/SH18084

</cite> [<a href="https://doi.org/10.1071/SH18084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30401342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sex%20Health&amp;title=Implementation%20of%20a%20community%20pharmacy-based%20pre-exposure%20prophylaxis%20service:%20a%20novel%20model%20for%20pre-exposure%20prophylaxis%20care&amp;author=EL%20Tung&amp;author=A%20Thomas&amp;author=A%20Eichner&amp;author=P%20Shalit&amp;volume=15&amp;issue=6&amp;publication_year=2018&amp;pages=556-61&amp;pmid=30401342&amp;doi=10.1071/SH18084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref015">
<span class="label">15.</span><cite>Lopez MI, Cocohoba J, Cohen SE, Trainor N, Levy MM, Dong BJ. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health. J Am Pharm Assoc. 2020;60(1):138–44. doi: 10.1016/j.japh.2019.06.021

</cite> [<a href="https://doi.org/10.1016/j.japh.2019.06.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31405804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Pharm%20Assoc&amp;title=Implementation%20of%20pre-exposure%20prophylaxis%20at%20a%20community%20pharmacy%20through%20a%20collaborative%20practice%20agreement%20with%20San%20Francisco%20Department%20of%20Public%20Health&amp;author=MI%20Lopez&amp;author=J%20Cocohoba&amp;author=SE%20Cohen&amp;author=N%20Trainor&amp;author=MM%20Levy&amp;volume=60&amp;issue=1&amp;publication_year=2020&amp;pages=138-44&amp;pmid=31405804&amp;doi=10.1016/j.japh.2019.06.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref016">
<span class="label">16.</span><cite>Havens JP, Scarsi KK, Sayles H, Klepser DG, Swindells S, Bares H. Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States. Open Forum Infect Dis. 2019;6(10).</cite> [<a href="https://doi.org/10.1093/ofid/ofz365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6765348/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31412131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Forum%20Infect%20Dis&amp;title=Acceptability%20and%20feasibility%20of%20a%20pharmacist-led%20HIV%20pre-exposure%20prophylaxis%20(PrEP)%20program%20in%20the%20Midwestern%20United%20States&amp;author=JP%20Havens&amp;author=KK%20Scarsi&amp;author=H%20Sayles&amp;author=DG%20Klepser&amp;author=S%20Swindells&amp;volume=6&amp;issue=10&amp;publication_year=2019&amp;pmid=31412131&amp;doi=10.1093/ofid/ofz365&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref017">
<span class="label">17.</span><cite>Khosropour CM, Backus KV, Means AR, Beauchamps L, Johnson K, Golden MR, et al. A pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation. AIDS Patient Care and STDS. 2020;34(1):1–6.
</cite> [<a href="https://doi.org/10.1089/apc.2019.0235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6983741/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31944854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS%20Patient%20Care%20and%20STDS&amp;title=A%20pharmacist-led,%20same-day,%20HIV%20pre-exposure%20prophylaxis%20initiation%20program%20to%20increase%20PrEP%20uptake%20and%20decrease%20time%20to%20PrEP%20initiation&amp;author=CM%20Khosropour&amp;author=KV%20Backus&amp;author=AR%20Means&amp;author=L%20Beauchamps&amp;author=K%20Johnson&amp;volume=34&amp;issue=1&amp;publication_year=2020&amp;pages=1-6&amp;pmid=31944854&amp;doi=10.1089/apc.2019.0235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref018">
<span class="label">18.</span><cite>Ortblad KF, Mogere P, Omollo V, Kuo AP, Asewe M, Gakuo S, et al. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation. J Int AIDS Soc. 2023;26(6):e26131. doi: 10.1002/jia2.26131

</cite> [<a href="https://doi.org/10.1002/jia2.26131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10258863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37306128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Int%20AIDS%20Soc&amp;title=Stand-alone%20model%20for%20delivery%20of%20oral%20HIV%20pre-exposure%20prophylaxis%20in%20Kenya:%20a%20single-arm,%20prospective%20pilot%20evaluation&amp;author=KF%20Ortblad&amp;author=P%20Mogere&amp;author=V%20Omollo&amp;author=AP%20Kuo&amp;author=M%20Asewe&amp;volume=26&amp;issue=6&amp;publication_year=2023&amp;pmid=37306128&amp;doi=10.1002/jia2.26131&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref019">
<span class="label">19.</span><cite>Okoro O, Hillman L. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health. J Am Pharm Assoc. 2018;58(4):412-420.e3. doi: 10.1016/j.japh.2018.04.007

</cite> [<a href="https://doi.org/10.1016/j.japh.2018.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29789257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Pharm%20Assoc&amp;title=HIV%20pre-exposure%20prophylaxis:%20Exploring%20the%20potential%20for%20expanding%20the%20role%20of%20pharmacists%20in%20public%20health&amp;author=O%20Okoro&amp;author=L%20Hillman&amp;volume=58&amp;issue=4&amp;publication_year=2018&amp;pmid=29789257&amp;doi=10.1016/j.japh.2018.04.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref020">
<span class="label">20.</span><cite>Mayer KH, Chan PA, R Patel R, Flash CA, Krakower DS. Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119–27. doi: 10.1097/QAI.0000000000001579

</cite> [<a href="https://doi.org/10.1097/QAI.0000000000001579" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5762416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29084044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Acquir%20Immune%20Defic%20Syndr&amp;title=Evolving%20Models%20and%20Ongoing%20Challenges%20for%20HIV%20Preexposure%20Prophylaxis%20Implementation%20in%20the%20United%20States&amp;author=KH%20Mayer&amp;author=PA%20Chan&amp;author=R%20R%20Patel&amp;author=CA%20Flash&amp;author=DS%20Krakower&amp;volume=77&amp;issue=2&amp;publication_year=2018&amp;pages=119-27&amp;pmid=29084044&amp;doi=10.1097/QAI.0000000000001579&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref021">
<span class="label">21.</span><cite>Kennedy CE, Yeh PT, Atkins K, Ferguson L, Baggaley R, Narasimhan M. PrEP distribution in pharmacies: a systematic review. BMJ Open. 2022;12(2):e054121. doi: 10.1136/bmjopen-2021-054121

</cite> [<a href="https://doi.org/10.1136/bmjopen-2021-054121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8860049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35190430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=PrEP%20distribution%20in%20pharmacies:%20a%20systematic%20review&amp;author=CE%20Kennedy&amp;author=PT%20Yeh&amp;author=K%20Atkins&amp;author=L%20Ferguson&amp;author=R%20Baggaley&amp;volume=12&amp;issue=2&amp;publication_year=2022&amp;pmid=35190430&amp;doi=10.1136/bmjopen-2021-054121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref022">
<span class="label">22.</span><cite>Shaeer KM, Sherman EM, Shafiq S, Hardigan P. Exploratory survey of Florida pharmacists’ experience, knowledge, and perception of HIV pre-exposure prophylaxis. J Am Pharm Assoc. 2014;54(6):610–7. doi: 10.1331/JAPhA.2014.14014

</cite> [<a href="https://doi.org/10.1331/JAPhA.2014.14014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25343624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Pharm%20Assoc&amp;title=Exploratory%20survey%20of%20Florida%20pharmacists%E2%80%99%20experience,%20knowledge,%20and%20perception%20of%20HIV%20pre-exposure%20prophylaxis&amp;author=KM%20Shaeer&amp;author=EM%20Sherman&amp;author=S%20Shafiq&amp;author=P%20Hardigan&amp;volume=54&amp;issue=6&amp;publication_year=2014&amp;pages=610-7&amp;pmid=25343624&amp;doi=10.1331/JAPhA.2014.14014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref023">
<span class="label">23.</span><cite>Unni EJ, Lian N, Kuykendall W. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state. J Am Pharm Assoc. 2016;56(5):527-532.e1. doi: 10.1016/j.japh.2016.05.004

</cite> [<a href="https://doi.org/10.1016/j.japh.2016.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27594106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Pharm%20Assoc&amp;title=Understanding%20community%20pharmacist%20perceptions%20and%20knowledge%20about%20HIV%20preexposure%20prophylaxis%20(PrEP)%20therapy%20in%20a%20Mountain%20West%20state&amp;author=EJ%20Unni&amp;author=N%20Lian&amp;author=W%20Kuykendall&amp;volume=56&amp;issue=5&amp;publication_year=2016&amp;pmid=27594106&amp;doi=10.1016/j.japh.2016.05.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref024">
<span class="label">24.</span><cite>Meyerson BE, Dinh PC Jr, Agley JD, Hill BJ, Motley DN, Carter GA, et al. Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP). AIDS Behav. 2019;23(7):1925–38. doi: 10.1007/s10461-018-02383-7

</cite> [<a href="https://doi.org/10.1007/s10461-018-02383-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8274484/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30607758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS%20Behav&amp;title=Predicting%20Pharmacist%20Dispensing%20Practices%20and%20Comfort%20Related%20to%20Pre-exposure%20Prophylaxis%20for%20HIV%20Prevention%20(PrEP)&amp;author=BE%20Meyerson&amp;author=PC%20Dinh&amp;author=JD%20Agley&amp;author=BJ%20Hill&amp;author=DN%20Motley&amp;volume=23&amp;issue=7&amp;publication_year=2019&amp;pages=1925-38&amp;pmid=30607758&amp;doi=10.1007/s10461-018-02383-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref025">
<span class="label">25.</span><cite>Przybyla SM, Parks K, Bleasdale J, Sawyer J, Morse D. Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students. Curr Pharm Teach Learn. 2019;11(4):352–60. doi: 10.1016/j.cptl.2019.01.011

</cite> [<a href="https://doi.org/10.1016/j.cptl.2019.01.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6800069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31040011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Pharm%20Teach%20Learn&amp;title=Awareness,%20knowledge,%20and%20attitudes%20towards%20human%20immunodeficiency%20virus%20(HIV)%20pre-exposure%20prophylaxis%20(PrEP)%20among%20pharmacy%20students&amp;author=SM%20Przybyla&amp;author=K%20Parks&amp;author=J%20Bleasdale&amp;author=J%20Sawyer&amp;author=D%20Morse&amp;volume=11&amp;issue=4&amp;publication_year=2019&amp;pages=352-60&amp;pmid=31040011&amp;doi=10.1016/j.cptl.2019.01.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref026">
<span class="label">26.</span><cite>Bunting SR, Feinstein BA, Hazra A, Sheth NK, Garber SS. Knowledge of HIV and HIV pre-exposure prophylaxis among medical and pharmacy students: A national, multi-site, cross-sectional study. Prev Med Rep. 2021;24:101590. doi: 10.1016/j.pmedr.2021.101590

</cite> [<a href="https://doi.org/10.1016/j.pmedr.2021.101590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8683973/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34976649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prev%20Med%20Rep&amp;title=Knowledge%20of%20HIV%20and%20HIV%20pre-exposure%20prophylaxis%20among%20medical%20and%20pharmacy%20students:%20A%20national,%20multi-site,%20cross-sectional%20study&amp;author=SR%20Bunting&amp;author=BA%20Feinstein&amp;author=A%20Hazra&amp;author=NK%20Sheth&amp;author=SS%20Garber&amp;volume=24&amp;publication_year=2021&amp;pages=101590&amp;pmid=34976649&amp;doi=10.1016/j.pmedr.2021.101590&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref027">
<span class="label">27.</span><cite>Malaysian Society for HIV Medicine (MASHM), Malaysian AIDS Foundation (MAF). HIV Connect [Internet]. Malaysian AIDS Foundation (MAF). 2022 [cited 2024 Mar 22]. Available from: <a href="https://www.openlearning.com/courses/hivconnect/?cl=1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.openlearning.com/courses/hivconnect/?cl=1</a></cite>
</li>
<li id="pone.0328713.ref028">
<span class="label">28.</span><cite>Moullin JC, Dickson KS, Stadnick NA, Rabin B, Aarons GA. Systematic review of the Exploration, Preparation, Implementation, Sustainment (EPIS) framework. Implement Sci. 2019;14(1):1. doi: 10.1186/s13012-018-0842-6

</cite> [<a href="https://doi.org/10.1186/s13012-018-0842-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6321673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30611302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Implement%20Sci&amp;title=Systematic%20review%20of%20the%20Exploration,%20Preparation,%20Implementation,%20Sustainment%20(EPIS)%20framework&amp;author=JC%20Moullin&amp;author=KS%20Dickson&amp;author=NA%20Stadnick&amp;author=B%20Rabin&amp;author=GA%20Aarons&amp;volume=14&amp;issue=1&amp;publication_year=2019&amp;pages=1&amp;pmid=30611302&amp;doi=10.1186/s13012-018-0842-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref029">
<span class="label">29.</span><cite>Malaysian Society for HIV Medicine (MASHM). Malaysian Consensus Guidelines on Antiretroviral Therapy. Sungai Buloh: Malaysian Society for HIV Medicine (MASHM); 2022.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Malaysian%20Consensus%20Guidelines%20on%20Antiretroviral%20Therapy&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref030">
<span class="label">30.</span><cite>Edpuzzle [Internet]. EDpuzzle Inc. 2024 [cited 2024 May 8]. Available from: <a href="https://edpuzzle.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://edpuzzle.com/</a></cite>
</li>
<li id="pone.0328713.ref031">
<span class="label">31.</span><cite>McKeirnan K, Czapinski J, Bertsch T, Buchman C, Akers J. Training Student Pharmacists to Perform Point-of-Care Testing. Am J Pharm Educ. 2019;83(7):7031. doi: 10.5688/ajpe7031

</cite> [<a href="https://doi.org/10.5688/ajpe7031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6788142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31619825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Pharm%20Educ&amp;title=Training%20Student%20Pharmacists%20to%20Perform%20Point-of-Care%20Testing&amp;author=K%20McKeirnan&amp;author=J%20Czapinski&amp;author=T%20Bertsch&amp;author=C%20Buchman&amp;author=J%20Akers&amp;volume=83&amp;issue=7&amp;publication_year=2019&amp;pages=7031&amp;pmid=31619825&amp;doi=10.5688/ajpe7031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref032">
<span class="label">32.</span><cite>Alzahrani MM, Alghamdi AA, Alghamdi SA, Alotaibi RK. Knowledge and Attitude of Dentists Towards Obstructive Sleep Apnea. Int Dent J. 2022;72(3):315–21. doi: 10.1016/j.identj.2021.05.004

</cite> [<a href="https://doi.org/10.1016/j.identj.2021.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9275360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34193341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Dent%20J&amp;title=Knowledge%20and%20Attitude%20of%20Dentists%20Towards%20Obstructive%20Sleep%20Apnea&amp;author=MM%20Alzahrani&amp;author=AA%20Alghamdi&amp;author=SA%20Alghamdi&amp;author=RK%20Alotaibi&amp;volume=72&amp;issue=3&amp;publication_year=2022&amp;pages=315-21&amp;pmid=34193341&amp;doi=10.1016/j.identj.2021.05.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref033">
<span class="label">33.</span><cite>Matyanga CMJ, Khoza S, Gavi AS. HIV pre-exposure prophylaxis: pharmacists knowledge, perception and willingness to adopt future implementation in a Zimbabwean urban setting. East Central African J Pharm Sci. 2014;17(1):3–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=East%20Central%20African%20J%20Pharm%20Sci&amp;title=HIV%20pre-exposure%20prophylaxis:%20pharmacists%20knowledge,%20perception%20and%20willingness%20to%20adopt%20future%20implementation%20in%20a%20Zimbabwean%20urban%20setting&amp;author=CMJ%20Matyanga&amp;author=S%20Khoza&amp;author=AS%20Gavi&amp;volume=17&amp;issue=1&amp;publication_year=2014&amp;pages=3-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref034">
<span class="label">34.</span><cite>Larsen DP, Butler AC, Aung WY, Corboy JR, Friedman DI, Sperling MR. The effects of test-enhanced learning on long-term retention in AAN annual meeting courses. Neurology. 2015;84(7):748–54. doi: 10.1212/WNL.0000000000001264

</cite> [<a href="https://doi.org/10.1212/WNL.0000000000001264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4336103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25609761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=The%20effects%20of%20test-enhanced%20learning%20on%20long-term%20retention%20in%20AAN%20annual%20meeting%20courses&amp;author=DP%20Larsen&amp;author=AC%20Butler&amp;author=WY%20Aung&amp;author=JR%20Corboy&amp;author=DI%20Friedman&amp;volume=84&amp;issue=7&amp;publication_year=2015&amp;pages=748-54&amp;pmid=25609761&amp;doi=10.1212/WNL.0000000000001264&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref035">
<span class="label">35.</span><cite>Hernick M. Test-Enhanced Learning in an Immunology and Infectious Disease Medicinal Chemistry/Pharmacology Course. Am J Pharm Educ. 2015;79(7):97. doi: 10.5688/ajpe79797

</cite> [<a href="https://doi.org/10.5688/ajpe79797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4812785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27168610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Pharm%20Educ&amp;title=Test-Enhanced%20Learning%20in%20an%20Immunology%20and%20Infectious%20Disease%20Medicinal%20Chemistry/Pharmacology%20Course&amp;author=M%20Hernick&amp;volume=79&amp;issue=7&amp;publication_year=2015&amp;pages=97&amp;pmid=27168610&amp;doi=10.5688/ajpe79797&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref036">
<span class="label">36.</span><cite>Salter SM, Karia A, Sanfilippo FM, Clifford RM. Effectiveness of E-learning in pharmacy education. Am J Pharm Educ. 2014;78(4):83. doi: 10.5688/ajpe78483

</cite> [<a href="https://doi.org/10.5688/ajpe78483" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4028592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24850945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Pharm%20Educ&amp;title=Effectiveness%20of%20E-learning%20in%20pharmacy%20education&amp;author=SM%20Salter&amp;author=A%20Karia&amp;author=FM%20Sanfilippo&amp;author=RM%20Clifford&amp;volume=78&amp;issue=4&amp;publication_year=2014&amp;pages=83&amp;pmid=24850945&amp;doi=10.5688/ajpe78483&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref037">
<span class="label">37.</span><cite>Lovero KL, Kemp CG, Wagenaar BH, Giusto A, Greene MC, Powell BJ, et al. Application of the Expert Recommendations for Implementing Change (ERIC) compilation of strategies to health intervention implementation in low- and middle-income countries: a systematic review. Implement Sci. 2023;18(1):56. doi: 10.1186/s13012-023-01310-2

</cite> [<a href="https://doi.org/10.1186/s13012-023-01310-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10617067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37904218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Implement%20Sci&amp;title=Application%20of%20the%20Expert%20Recommendations%20for%20Implementing%20Change%20(ERIC)%20compilation%20of%20strategies%20to%20health%20intervention%20implementation%20in%20low-%20and%20middle-income%20countries:%20a%20systematic%20review&amp;author=KL%20Lovero&amp;author=CG%20Kemp&amp;author=BH%20Wagenaar&amp;author=A%20Giusto&amp;author=MC%20Greene&amp;volume=18&amp;issue=1&amp;publication_year=2023&amp;pages=56&amp;pmid=37904218&amp;doi=10.1186/s13012-023-01310-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref038">
<span class="label">38.</span><cite>Ashcraft LE, Goodrich DE, Hero J, Phares A, Bachrach RL, Quinn DA, et al. A systematic review of experimentally tested implementation strategies across health and human service settings: evidence from 2010-2022. Implement Sci. 2024;19(1):43. doi: 10.1186/s13012-024-01369-5

</cite> [<a href="https://doi.org/10.1186/s13012-024-01369-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11194895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38915102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Implement%20Sci&amp;title=A%20systematic%20review%20of%20experimentally%20tested%20implementation%20strategies%20across%20health%20and%20human%20service%20settings:%20evidence%20from%202010-2022&amp;author=LE%20Ashcraft&amp;author=DE%20Goodrich&amp;author=J%20Hero&amp;author=A%20Phares&amp;author=RL%20Bachrach&amp;volume=19&amp;issue=1&amp;publication_year=2024&amp;pages=43&amp;pmid=38915102&amp;doi=10.1186/s13012-024-01369-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref039">
<span class="label">39.</span><cite>Challa KT, Sayed A, Acharya Y. Modern techniques of teaching and learning in medical education: a descriptive literature review. MedEdPublish (2016). 2021;10:18. doi: 10.15694/mep.2021.000018.1

</cite> [<a href="https://doi.org/10.15694/mep.2021.000018.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10939590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38486533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=MedEdPublish%20(2016)&amp;title=Modern%20techniques%20of%20teaching%20and%20learning%20in%20medical%20education:%20a%20descriptive%20literature%20review&amp;author=KT%20Challa&amp;author=A%20Sayed&amp;author=Y%20Acharya&amp;volume=10&amp;publication_year=2021&amp;pages=18&amp;pmid=38486533&amp;doi=10.15694/mep.2021.000018.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref040">
<span class="label">40.</span><cite>Roche SD, Were D, Crawford ND, Tembo A, Pintye J, Bukusi E, et al. Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions. Curr HIV/AIDS Rep. 2024;21(3):116–30. doi: 10.1007/s11904-024-00696-y

</cite> [<a href="https://doi.org/10.1007/s11904-024-00696-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11129962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38517671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20HIV/AIDS%20Rep&amp;title=Getting%20HIV%20Pre-exposure%20Prophylaxis%20(PrEP)%20into%20Private%20Pharmacies:%20Global%20Delivery%20Models%20and%20Research%20Directions&amp;author=SD%20Roche&amp;author=D%20Were&amp;author=ND%20Crawford&amp;author=A%20Tembo&amp;author=J%20Pintye&amp;volume=21&amp;issue=3&amp;publication_year=2024&amp;pages=116-30&amp;pmid=38517671&amp;doi=10.1007/s11904-024-00696-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref041">
<span class="label">41.</span><cite>Loh P, Chua SS, Karuppannan M. The extent and barriers in providing pharmaceutical care services by community pharmacists in Malaysia: a cross-sectional study. BMC Health Serv Res. 2021;21(1):822. doi: 10.1186/s12913-021-06820-7

</cite> [<a href="https://doi.org/10.1186/s12913-021-06820-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8365940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34399749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Health%20Serv%20Res&amp;title=The%20extent%20and%20barriers%20in%20providing%20pharmaceutical%20care%20services%20by%20community%20pharmacists%20in%20Malaysia:%20a%20cross-sectional%20study&amp;author=P%20Loh&amp;author=SS%20Chua&amp;author=M%20Karuppannan&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pages=822&amp;pmid=34399749&amp;doi=10.1186/s12913-021-06820-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0328713.ref042">
<span class="label">42.</span><cite>Verma RK, Chong WW, Taha NA, Paraidathathu T. Impact of an Educational Training Program on the Knowledge, Attitude, and Perceived Barriers of Community Pharmacists Towards Obesity and Overweight Management in Malaysia. Front Public Health. 2021;9:720939. doi: 10.3389/fpubh.2021.720939

</cite> [<a href="https://doi.org/10.3389/fpubh.2021.720939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8440900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34540790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Public%20Health&amp;title=Impact%20of%20an%20Educational%20Training%20Program%20on%20the%20Knowledge,%20Attitude,%20and%20Perceived%20Barriers%20of%20Community%20Pharmacists%20Towards%20Obesity%20and%20Overweight%20Management%20in%20Malaysia&amp;author=RK%20Verma&amp;author=WW%20Chong&amp;author=NA%20Taha&amp;author=T%20Paraidathathu&amp;volume=9&amp;publication_year=2021&amp;pages=720939&amp;pmid=34540790&amp;doi=10.3389/fpubh.2021.720939&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0328713.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0328713.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Ali Ahmed</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Ali Ahmed</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Ahmed</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Ali Ahmed</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2025 Ali Ahmed</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>13 Feb 2025</em>
</p>
<p>PONE-D-24-57343Development and delivery of an online HIV pre-exposure prophylaxis (PrEP) training for community pharmacists to prepare for the implementation of a pharmacy-led PrEP service in Malaysia.PLOS ONE</p>
<p>Dear Dr. Zaki,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Mar 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Ali Ahmed, PhD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal requirements:   When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at <a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and <a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>. 2. Please upload a copy of Supplemental Information File 1 and Supplemental Information File 2 to which you refer in your text on page 9. Please amend the file type to 'Supporting Information'. If the Supplementary file is no longer to be included as part of the submission please remove all reference to it within the text.</p>
<p>Additional Editor Comments:</p>
<p>I have only concern of sample diversity as most of participants are chinese, given the diversity of Malaysia. Does this impact the implications of your findings?</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #1: Partly</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Partly</p>
<p>**********</p>
<p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #1: I Don't Know</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p>5. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: Consider revising the title - Development and delivery of an online HIV pre-exposure prophylaxis (PrEP) training for community pharmacists to prepare for the implementation of a pharmacy-led PrEP service in Malaysia. This title could be made more explicit e.g., Development and Evaluation of an Online PrEP Training Program for Community Pharmacists to Enhance Pharmacy-Led HIV Prevention Services in Malaysia</p>
<p>Abstract- The phrases "stigmatized key populations" and "non-traditional differentiated service delivery models, like pharmacies" are slightly repetitive when describing the rationale. Simplify for conciseness. While informative, the committee, platform, and timeline description could be condensed. Focus on the core aspects, such as the training content, evaluation tools, and key methodological steps. While the results highlight the improvement in knowledge scores, the discussion of gaps in knowledge and variability among participants is not explored sufficiently. Briefly mention specific gaps to better contextualize the need for enhanced training methods. Link participant demographics to their potential impact on training outcomes. While the conclusion mentions the need for modern methodologies, it does not connect how these would address the identified gaps.</p>
<p>Introduction- While the introduction thoroughly describes the HIV epidemic in Malaysia, key affected populations, and existing service delivery gaps, it is overly detailed, with some points repeated unnecessarily, e.g., barriers to public healthcare facilities and the potential of pharmacy-based models. The transition between some paragraphs feels abrupt, particularly when discussing global recommendations, local implementation, and the rationale for pharmacy-led models. The introduction outlines the problem well but doesn't sufficiently emphasize how the study addresses these gaps.</p>
<p>The Materials and Methods section provides detailed descriptions of the study's design, processes, and tools, which is commendable. The EPIS framework adds rigor and aligns the study within a recognized implementation science framework, strengthening the study's credibility. However, the section is densely packed with information, making it challenging to follow. Key components like "Development of the training program," "Delivery," and "Data analysis" could be more distinct. Breaking the section into clearly labeled subsections, e.g., Training Program Development, Study Design, Participant Recruitment, Training Delivery, Evaluation, and Data Analysis, would improve readability. Certain details, e.g., repeated mentions of module content and pre/post-test descriptions, are unnecessarily repeated. While the stakeholder consultation is mentioned, its contributions to the training program development are not elaborated upon. The author should highlight specific insights or recommendations from stakeholders that informed the program design to strengthen the relevance of the consultation. There is insufficient explanation of why particular tools, e.g., Edpuzzle and Google Forms, were chosen. The section uses long paragraphs that make key details hard to locate.</p>
<p>Results -The results section contains substantial data organized around demographic characteristics, pre- and post-training knowledge scores, feedback on the training program, and participant suggestions for improvement. Demographic information is detailed but repetitive, with percentages mentioned in both text and table form. Summarize key demographic trends in the text and refer readers to the table for further details. Table 3 presents data participant-by-participant, which may not be necessary for interpretation. Condense Table 3 to highlight summary statistics (mean, SD, minimum, maximum, p-value) without individual scores. The narrative describing pre- and post-training knowledge scores is overly general and does not critically engage with the data. For example, the statement “the online training appears insufficient” is unsupported by nuanced analysis. Provide a more detailed interpretation of the data. The feedback is summarized well but lacks a deeper synthesis or connection to broader findings. Authors need to analyze feedback to identify recurring themes, e.g., clarity of clinical content, need for quizzes, the pacing of modules, etc, and link these themes to observed knowledge gaps.</p>
<p>Discussion section—While improving knowledge scores is significant, the discussion could delve deeper into how these scores translate into practical application or readiness to provide PrEP services. The discussion briefly mentions areas where the training fell short, e.g., indications, side effects, and contraindications, but it does not explore why these gaps persist or propose specific ways to address them in future iterations. While participant feedback is mentioned, the discussion does not thoroughly analyze or contextualize it. For example, the perceived disconnect between participants’ satisfaction and actual knowledge gains could be explored in more depth. The discussion does not sufficiently address potential barriers to implementing the training program on a larger scale, such as resource constraints, internet accessibility, or variations in pharmacists' baseline knowledge. While the study's relevance to public health goals is noted, e.g., achieving zero new HIV infections in Malaysia by 2030, the practical steps needed to integrate pharmacists into the national PrEP service framework are not discussed. Although the ERIC taxonomy is cited, its application in this context is not detailed. Explaining how ERIC strategies could specifically enhance pharmacist training would strengthen the argument.</p>
<p>Conclusions—The conclusions summarize the study's key findings, emphasizing the novelty and effectiveness of the online PrEP training program in increasing pharmacists' knowledge. However, there is an overgeneralization. For example, while the training program improved knowledge, the conclusions imply broader success without fully addressing the uneven knowledge gains among participants or the remaining critical knowledge gaps. Recommendations for incorporating advanced learning methodologies are mentioned but lack specificity. For example, how case-based or simulation-based learning could be practically integrated is not explored. The conclusions do not discuss potential logistical or systemic challenges, e.g., funding, time constraints, or accessibility issues that might hinder nationwide program implementation. There is little mention of how increased pharmacist knowledge translates into actual improvements in PrEP service delivery or uptake in Malaysia. While knowledge improvement is highlighted, confidence and skill in counseling and service provision are not sufficiently addressed, even though they are critical for successful PrEP delivery.</p>
<p>Reviewer #2: Congratulations to the authors for the well written manuscript. The manuscript highlights a salient issue on the development and delivery of online PrEP training for new cadres such as pharmacy providers in the context of task shifting services. Two issues for consideration:</p>
<p>1. The title of the manuscript gives prominence to the development and delivery of the online training. However, the primary substance of the manuscript is on PrEP knowledge gains from undertaking the training. Would the authors consider reframing their title to address the primary focus of their manuscript.</p>
<p>2. The limitations of the study are well described but no strengths are included. It would be good to read why the authors think this research adds to the field and why their study is a strong one.</p>
<p>Reviewer #3: OVERALL: This manuscript focuses on development and assessment of an online, self-paced PrEP training program for community pharmacist for PrEP delivery in Malaysia. This is the first known assessment of such a training program in Malaysia and adds to the sparse literature on how pharmacy providers could be trained to deliver PrEP services in Malaysia and other global settings. While addressing an important topic, some further details on how the training was developed and what went into development of the assessment tools would be helpful. Additionally, it isn’t clear why the authors choose to only describe the online component of this training program and not the in-person training that followed—which seemed to utilize many of the training strategies the authors suggest for enhancement of the online training module. I think presenting both training components together would enhance this paper and present a wholistic package of how pharmacy providers might be trained on PrEP delivery. Further, both the Introduction and Discussion of the paper could be revised for clarity and focus.</p>
<p>MAJOR:</p>
<p>• (Abstract, Results): It isn’t clear how to interpret the “knowledge score”. How was this constructed and scored; what types of questions were included in this assessment?</p>
<p>• (Abstract, Results): It is not totally clear what you mean from the following sentence: “While training significantly improved knowledge scores, it did not produce consistent knowledge gains for all participants or address some critical PrEP knowledge gaps”. Can you be more specific on the gaps of interest? And how many participants didn’t have knowledge gains?</p>
<p>• (Abstract, Conclusions): Might temper conclusions because not proving in this abstract that pharmacy PrEP delivery increases PrEP access.</p>
<p>• (Introduction): The introduction could be abbreviated for focus and clarity.</p>
<p>• (Methods): How was the content of the open-ended questions analyzed? Which subsequently led to key themes on the most useful aspects of the training and areas for improvement presented in the Results?</p>
<p>• (Discussion, paragraph 2): Still not clear where your suggested threshold of 80% knowledge comes from. Seems arbitrary to suggest such threshold if different knowledge assessments using different tools.</p>
<p>• (Methods): Details on how pharmacists were trained on HIV testing required for PrEP delivery missing. Especially since this might require in-person practice that is difficult to delivery remotely.</p>
<p>• (Discussion): Unclear what you would measure the effect of training on? If using as an ERIC implementation strategy, wouldn’t the ultimate outcome be PrEP uptake at the pharmacy versus knowledge among providers? And you did see a positive change in knowledge among providers post-training, so unclear why you are suggesting that the training wasn’t effective at knowledge gain?</p>
<p>• (Discussion): You note that modern learning methodologies (e.g., case-based, team-based) could improve knowledge outcomes among pharmacy providers – in the methods, might be worth mentioning why you didn’t incorporate any of these approaches when you developed this online training.</p>
<p>• (Discussion): IF the online training was just part one of provider training, followed by the in-person training – why is the in-person training not included in this manuscript to complete the discussion of how you might train pharmacy providers for PrEP delivery?</p>
<p>• (Discussion &amp; limitations): These sections of the paper are long and could be abbreviated for focus and clarity.</p>
<p>MINOR:</p>
<p>• (Formatting): Formatting of the current manuscript is a little confusing – the distinction between sections and subsections is not clear. Additional subsections (e.g., data collection, analysis) in the methods could enhance clarity.</p>
<p>• (Methods): The April 2023 stakeholder meeting is mentioned without details on what types of stakeholders attended this meeting and what was discussed. Adding a brief description of this would be helpful.</p>
<p>• (Methods, Delivery of the online self-paced PrEP training program): Would suggest moving several details here (e.g., who attended the training, duration of engagement) to the Results section.</p>
<p>• (Results, Table 3): Not sure inclusion of this table in the main paper is necessary – would suggest including as an appendix, if want to keep.</p>
<p>• (Results, Table 4): Would consider adding a column that is the % change from pre- to pos-training assessment. Could include overall score across question at bottom of this table (i.e., info in Table 3).</p>
<p>**********</p>
<p>6. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: <strong>Yes: </strong> Daniel Were</p>
<p>Reviewer #3: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0328713.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 18;20(8):e0328713. doi: <a href="https://doi.org/10.1371/journal.pone.0328713.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>30 Apr 2025</em>
</p>
<p>Dr. Rafdzah Ahmad Zaki</p>
<p>Public Health Medicine Specialist and Professor,</p>
<p>Department of Social and Preventive Medicine,</p>
<p>Faculty of Medicine</p>
<p>Universiti Malaya, Malaysia</p>
<p>rafdzah@ummc.edu.my</p>
<p>25th April 2025</p>
<p>Editor-in-Chief</p>
<p>PLOS ONE</p>
<p>Subject: Rebuttal Letter for Manuscript Revision (PONE-D-24-57343)</p>
<p>Dear Dr. Ali Ahmed,</p>
<p>We sincerely appreciate the opportunity to revise our manuscript, titled "Development and delivery of an online HIV pre-exposure prophylaxis (PrEP) training for community pharmacists to prepare for the implementation of a pharmacy-led PrEP service in Malaysia" (Manuscript ID: PONE-D-24-57343).</p>
<p>We are grateful for the constructive feedback provided by the reviewers and the academic editor. We have carefully addressed each of the comments and have made the necessary revisions to enhance the clarity and quality of our manuscript. Below, we provide a point-by-point response to each comment, detailing the changes made.</p>
<p>________________________________________</p>
<p>Journal requirements:</p>
<p>Comment: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and <a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>.</p>
<p>Response: We have reviewed and updated our manuscript to ensure compliance with PLOS ONE’s style requirements, including formatting and file naming conventions. The revised manuscript follows the guidelines provided in the PLOS ONE style templates.</p>
<p>Comment: Please upload a copy of Supplemental Information File 1 and Supplemental Information File 2 to which you refer in your text on page 9. Please amend the file type to 'Supporting Information'. If the Supplementary file is no longer to be included as part of the submission, please remove all reference to it within the text.</p>
<p>Response: We have uploaded Supplemental Information File 1 and Supplemental Information File 2 as 'Supporting Information' files, as per the journal’s requirements. It was initially included in the manuscript under S1 Appendix and S2 Appendix. Additionally, we have ensured that all references to these files within the manuscript are accurate.</p>
<p>________________________________________</p>
<p>Response to the Academic Editor’s Comments:</p>
<p>Comment: I have only concern of sample diversity as most of participants are Chinese, given the diversity of Malaysia. Does this impact the implications of your findings?</p>
<p>Response: We acknowledge this concern and have addressed it in the manuscript. The predominance of Chinese pharmacists in our sample reflects the demographic distribution in private pharmacies in Malaysia. However, the training program was adapted from local PrEP training for general practitioners and follows local guidelines and core PrEP competencies applicable to all pharmacists. Future efforts will focus on broader outreach to enhance diversity in participation.</p>
<p>________________________________________</p>
<p>Response to Reviewer 1’s Comments:</p>
<p>Comment 1: Consider revising the title - Development and delivery of an online HIV pre-exposure prophylaxis (PrEP) training for community pharmacists to prepare for the implementation of a pharmacy-led PrEP service in Malaysia. This title could be made more explicit e.g., Development and Evaluation of an Online PrEP Training Program for Community Pharmacists to Enhance Pharmacy-Led HIV Prevention Services in Malaysia.</p>
<p>Response: We agree and revised the title to “Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia”.</p>
<p>Comment 2: Abstract - The phrases "stigmatized key populations" and "non-traditional differentiated service delivery models, like pharmacies" are slightly repetitive when describing the rationale. Simplify for conciseness. While informative, the committee, platform, and timeline description could be condensed. Focus on the core aspects, such as the training content, evaluation tools, and key methodological steps. While the results highlight the improvement in knowledge scores, the discussion of gaps in knowledge and variability among participants is not explored sufficiently. Briefly mention specific gaps to better contextualize the need for enhanced training methods. Link participant demographics to their potential impact on training outcomes. While the conclusion mentions the need for modern methodologies, it does not connect how these would address the identified gaps.</p>
<p>Response: The abstract has been refined to enhance clarity and remove redundant phrases while maintaining key information on training content, evaluation, and methodological aspects.</p>
<p>Comment 3: Introduction - While the introduction thoroughly describes the HIV epidemic in Malaysia, key affected populations, and existing service delivery gaps, it is overly detailed, with some points repeated unnecessarily, e.g., barriers to public healthcare facilities and the potential of pharmacy-based models. The transition between some paragraphs feels abrupt, particularly when discussing global recommendations, local implementation, and the rationale for pharmacy-led models. The introduction outlines the problem well but doesn't sufficiently emphasize how the study addresses these gaps.</p>
<p>Response: We have streamlined the introduction to reduce redundancy and tightened the narrative, particularly around barriers to existing service delivery and the rationale for pharmacy-based models. Transitions between paragraphs have been improved to ensure a more coherent flow from global recommendations to local implementation efforts. We have also revised the final paragraph to more explicitly state how our study addresses the identified gaps by developing and piloting an online PrEP training module specifically for community pharmacists—an essential step toward enabling future pharmacy-led PrEP service delivery in Malaysia.</p>
<p>Comment 4: The Materials and Methods section provides detailed descriptions of the study's design, processes, and tools, which is commendable. The EPIS framework adds rigor and aligns the study within a recognized implementation science framework, strengthening the study's credibility. However, the section is densely packed with information, making it challenging to follow. Key components like "Development of the training program," "Delivery," and "Data analysis" could be more distinct. Breaking the section into clearly labeled subsections, e.g., Training Program Development, Study Design, Participant Recruitment, Training Delivery, Evaluation, and Data Analysis, would improve readability. Certain details, e.g., repeated mentions of module content and pre/post-test descriptions, are unnecessarily repeated. While the stakeholder consultation is mentioned, its contributions to the training program development are not elaborated upon. The author should highlight specific insights or recommendations from stakeholders that informed the program design to strengthen the relevance of the consultation. There is insufficient explanation of why particular tools, e.g., Edpuzzle and Google Forms, were chosen. The section uses long paragraphs that make key details hard to locate.</p>
<p>Response: We agree and have included subsections to improve clarity and reduced redundancy. The use of Edpuzzle and Google Forms are not necessarily salient here, but we include them to ensure that readers understand which methods we selected – mostly for ease when interacting with participants. We do, however, provide more explanation for how these platforms work and why we used them.</p>
<p>Comment 5: Results -The results section contains substantial data organized around demographic characteristics, pre- and post-training knowledge scores, feedback on the training program, and participant suggestions for improvement. Demographic information is detailed but repetitive, with percentages mentioned in both text and table form. Summarize key demographic trends in the text and refer readers to the table for further details. Table 3 presents data participant-by-participant, which may not be necessary for interpretation. Condense Table 3 to highlight summary statistics (mean, SD, minimum, maximum, p-value) without individual scores. The narrative describing pre- and post-training knowledge scores is overly general and does not critically engage with the data. For example, the statement “the online training appears insufficient” is unsupported by nuanced analysis. Provide a more detailed interpretation of the data. The feedback is summarized well but lacks a deeper synthesis or connection to broader findings. Authors need to analyze feedback to identify recurring themes, e.g., clarity of clinical content, need for quizzes, the pacing of modules, etc, and link these themes to observed knowledge gaps.</p>
<p>Response: We appreciate the reviewer’s detailed feedback and have revised the Results section accordingly. To reduce redundancy, we have summarized key demographic trends in the text while referring readers to the table for details. In Table 3, we have added a column showing the percentage change in scores and the overall percentage change across participants. We believe retaining this table in the main manuscript is important to illustrate individual pre- and post-training scores, especially since four participants did not show improvement after training. Additionally, we have refined the discussion of knowledge scores to provide a more critical interpretation of the data, ensuring conclusions are supported by nuanced analysis.</p>
<p>To provide a more critical engagement with the data and to address the reviewer’s suggestion to link participant demographics to training outcomes, we conducted additional statistical analyses that were not part of the original manuscript. Specifically, independent t-tests were used to examine differences in post-training knowledge scores by gender (male vs. female), education level (undergraduate vs. postgraduate), and prior HIV-related training (yes vs. no), while one-way ANOVA was used to compare scores across age groups, ethnicities, and years of professional experience. These analyses are now described in the Data Analysis subsection of the Methods, with results reported briefly in the Results section. No statistically significant differences were found across these demographic variables, suggesting that the online training program was broadly effective regardless of participants’ background characteristics. However, this finding should be interpreted with caution due to the small sample size, which we have acknowledged as a limitation in the revised manuscript.</p>
<p>The statement on training sufficiency has been revised for accuracy. We have also expanded the synthesis of participant feedback, identifying recurring themes such as clarity of clinical content, the need for interactive elements (e.g., quizzes), and module pacing, linking these to observed knowledge gaps for a more comprehensive interpretation.</p>
<p>Comment 6: Discussion section—While improving knowledge scores is significant, the discussion could delve deeper into how these scores translate into practical application or readiness to provide PrEP services. The discussion briefly mentions areas where the training fell short, e.g., indications, side effects, and contraindications, but it does not explore why these gaps persist or propose specific ways to address them in future iterations. While participant feedback is mentioned, the discussion does not thoroughly analyze or contextualize it. For example, the perceived disconnect between participants’ satisfaction and actual knowledge gains could be explored in more depth. The discussion does not sufficiently address potential barriers to implementing the training program on a larger scale, such as resource constraints, internet accessibility, or variations in pharmacists' baseline knowledge. While the study's relevance to public health goals is noted, e.g., achieving zero new HIV infections in Malaysia by 2030, the practical steps needed to integrate pharmacists into the national PrEP service framework are not discussed. Although the ERIC taxonomy is cited, its application in this context is not detailed. Explaining how ERIC strategies could specifically enhance pharmacist training would strengthen the argument.</p>
<p>Response: We agree and have expanded the Discussion section to better contextualize how improved knowledge scores translate into pharmacists' readiness to provide PrEP services. We have explored persistent knowledge gaps, particularly in indications, side effects, and contraindications, and proposed strategies such as case-based learning. Additionally, we have noted that in-person training included a review and discussion of questions with lower correct response rates. We have also analysed the disconnect between participant satisfaction and actual knowledge gains and expanded discussions on barriers to scaling up the training, including resource constraints and baseline knowledge variations. To strengthen relevance to national public health goals, we have outlined practical steps for integrating pharmacists into Malaysia’s PrEP service framework, including policy support, pharmacist certification pathways, and collaboration with healthcare providers. Finally, we have elaborated on the application of ERIC strategies that might be useful to enhance implementation.</p>
<p>Comment 7: Conclusions—The conclusions summarize the study's key findings, emphasizing the novelty and effectiveness of the online PrEP training program in increasing pharmacists' knowledge. However, there is an overgeneralization. For example, while the training program improved knowledge, the conclusions imply broader success without fully addressing the uneven knowledge gains among participants or the remaining critical knowledge gaps. Recommendations for incorporating advanced learning methodologies are mentioned but lack specificity. For example, how case-based or simulation-based learning could be practically integrated is not explored. The conclusions do not discuss potential logistical or systemic challenges, e.g., funding, time constraints, or accessibility issues that might hinder nationwide program implementation. There is little mention of how increased pharmacist knowledge translates into actual improvements in PrEP service delivery or uptake in Malaysia. While knowledge improvement is highlighted, confidence and skill in counseling and service provision are not sufficiently addressed, even though they are critical for successful PrEP delivery.</p>
<p>Response: We agree and have revised the Conclusions section to avoid over-generalization and ensure a more balanced interpretation of the findings. We now acknowledge the variability in knowledge gains among participants and highlight remaining critical knowledge gaps. Additionally, we have specified how active learning methodologies, such as case-based and simulation-based learning, could be practically integrated into future training to enhance the development of applied skills. We have also included a discussion on potential logistical and systemic challenges, such as funding, time constraints, and accessibility issues, that may affect nationwide implementation. While this study focused on improving pharmacists’ knowledge as a foundational step toward implementation readiness, we have acknowledged in the limitations that we did not assess confidence or counselling skills directly. We have clarified in the conclusions section that future research should explore how knowledge improvement translates into real-world counselling skills, confidence, and effective PrEP service delivery outcomes.</p>
<p>________________________________________</p>
<p>Response to Reviewer 2’s Comments:</p>
<p>Congratulations to the authors for the well written manuscript. The manuscript highlights a salient issue on the development and delivery of online PrEP training for new cadres such as pharmacy providers in the context of task shifting services. Two issues for consideration:</p>
<p>Comment 1: The title of the manuscript gives prominence to the development and delivery of the online training. However, the primary substance of the manuscript is on P</p>
<section class="sm xbox font-sm" id="pone.0328713.s004"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s004.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s004.docx</a><sup> (48.8KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0328713.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0328713.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Ali Ahmed</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Ali Ahmed</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Ahmed</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Ali Ahmed</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2025 Ali Ahmed</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>21 May 2025</em>
</p>
<p>PONE-D-24-57343R1Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia.PLOS ONE</p>
<p>Dear Dr. Zaki,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Jul 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Ali Ahmed, PhD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
<p>Reviewer #4: (No Response)</p>
<p>**********</p>
<p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>3. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #4: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #4: My comments are:</p>
<p>Line 106: Can you explain what you mean by strategic task shifting?</p>
<p>What modifications were made while adapting the physician-targeted training program for pharmacists?</p>
<p>Line 402: The word ‘cisgender’ may need explanation.</p>
<p>Can more details about the in-person workshop be provided?</p>
<p>Lines 486 to 489. A sentence is repeated.</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #4: <strong>Yes: </strong> Pathiyil Ravi Shankar</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0328713.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 18;20(8):e0328713. doi: <a href="https://doi.org/10.1371/journal.pone.0328713.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 2</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.f" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.f" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub4" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.f" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>3 Jul 2025</em>
</p>
<p>Dr. Rafdzah Ahmad Zaki</p>
<p>Public Health Medicine Specialist and Professor,</p>
<p>Department of Social and Preventive Medicine,</p>
<p>Faculty of Medicine</p>
<p>Universiti Malaya, Malaysia</p>
<p>rafdzah@ummc.edu.my</p>
<p>25th June 2025</p>
<p>Editor-in-Chief</p>
<p>PLOS ONE</p>
<p>Subject: Rebuttal Letter for Manuscript Revision [PONE-D-24-57343R1] - [EMID:7ee32a2b256e6417]</p>
<p>Dear Dr. Ali Ahmed,</p>
<p>We sincerely appreciate the opportunity to revise our manuscript, titled "Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia." (Manuscript ID: PONE-D-24-57343R1).</p>
<p>We are grateful for the constructive feedback provided by the reviewer. We have carefully addressed each of the comment and have made the necessary revisions to enhance the clarity and quality of our manuscript. Below, we provide a point-by-point response to each comment, detailing the changes made.</p>
<p>________________________________________</p>
<p>Journal requirements:</p>
<p>Comment: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>Response: We have carefully reviewed the reference list to ensure its completeness and accuracy. All citations were cross-checked, and no retracted articles were identified. Therefore, no rationale for including retracted references was necessary. Minor formatting corrections were also made where appropriate, and these are reflected in the revised manuscript.</p>
<p>The reference below has been added to replace the previously cited newspaper articles, as the official statistics on the number of PrEP users as well as the number of government clinics providing PrEP services are now available in the Malaysian Global AIDS Monitoring Report 2024.</p>
<p>3. Ministry of Health Malaysia. 2024 Global AIDS Monitoring: Country Progress Report - Malaysia. Putrajaya; Ministry of Health Malaysia; 2024.</p>
<p>3. Ministry of Health Malaysia. 2023 Global AIDS Monitoring: Country Progress Report - Malaysia. Putrajaya: Ministry of Health Malaysia; 2023.</p>
<p>8. Vethasalam R, Tan T, Gimino G, Lee B. More than 2000 individuals given PrEP to reduce HIV infections, says Dr Zaliha. Star [Internet]. 2023 Nov 7 [cited 2024 Mar 22]; Available from: <a href="https://www.thestar.com.my/news/nation/2023/11/07/more-than-2000-individuals-given-prep-to-reduce-hiv-infections-says-dr-zaliha" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.thestar.com.my/news/nation/2023/11/07/more-than-2000-individuals-given-prep-to-reduce-hiv-infections-says-dr-zaliha</a></p>
<p>11. Ibrahim J, Rahim R, Lai A, Pfordten D. Ten more govt clinics to start dispensing HIV prevention drugs, says Dr Dzulkefly. Star [Internet]. 2024 Mar 20 [cited 2024 Mar 22]; Available from: <a href="https://www.thestar.com.my/news/nation/2024/03/20/ten-more-govt-clinics-to-start-dispensing-hiv-prevention-drugs-says-dr-dzulkefly" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.thestar.com.my/news/nation/2024/03/20/ten-more-govt-clinics-to-start-dispensing-hiv-prevention-drugs-says-dr-dzulkefly</a></p>
<p>Additionally, please find below the references that were added in the first revision but were not mentioned in the previous rebuttal letter.</p>
<p>31. McKeirnan K, Czapinski J, Bertsch T, Buchman C, Akers J. Training Student Pharmacists to Perform Point-of-Care Testing. American Journal of Pharmaceutical Education. 2019;83(7):7031.</p>
<p>32. Alzahrani MM, Alghamdi AA, Alghamdi SA, Alotaibi RK. Knowledge and Attitude of Dentists Towards Obstructive Sleep Apnea. International Dental Journal. 2022;72(3):315–21.</p>
<p>41. Loh P, Chua SS, Karuppannan M. The extent and barriers in providing pharmaceutical care services by community pharmacists in Malaysia: a cross-sectional study. BMC Health Services Research. 2021;21:1–14.</p>
<p>________________________________________</p>
<p>Response to Reviewer 4’s Comments:</p>
<p>Comment 1: Line 106: Can you explain what you mean by strategic task shifting?</p>
<p>Response: We have revised the sentence to clarify the meaning of strategic task-shifting as follows:</p>
<p>"Furthermore, community pharmacists are well-trained healthcare professionals and well-positioned to provide PrEP services through strategic task-shifting, which involves the appropriate reallocation of responsibilities such as counselling and dispensing from physicians to pharmacists to improve service delivery and access."</p>
<p>Comment 2: What modifications were made while adapting the physician-targeted training program for pharmacists?</p>
<p>Response: We have clarified this in the revised manuscript under “training program development”. While adapting the physician-targeted HIV Connect PrEP course for pharmacists, we simplified certain content to focus more on oral PrEP (tenofovir disoproxil fumarate/emtricitabine), rather than options that were either unavailable or not approved for PrEP in Malaysia at the time, such as tenofovir alafenamide/emtricitabine (TAF/FTC), long-acting injectable cabotegravir, and the dapivirine ring. A summary of special circumstances was added to aid comprehension. Additionally, implementation-focused videos were incorporated to provide practical guidance on key aspects of the pharmacy-led PrEP service, including checklists for PrEP initiation and follow-up, adherence assessment and counselling, and referral pathways (when and who to refer). These modifications were made to align the training with pharmacists’ scope of practice and enhance implementation readiness.</p>
<p>Comment 3: Line 402: The word ‘cisgender’ may need explanation.</p>
<p>Response: We appreciate the reviewer’s comment. “Cisgender” is a commonly used term in public health literature and reflects the terminology used in the cited article. However, to improve clarity and consistency, we have revised the term to “cisgender men who have sex with men (MSM)” in the manuscript.</p>
<p>Comment 4: Can more details about the in-person workshop be provided?</p>
<p>Response: Thank you for this suggestion. As the primary focus of this manuscript is the development and evaluation of the online PrEP training program, we have kept the description of the in-person workshop concise in the Materials and methods section to avoid shifting focus. However, additional details about the workshop have been included in the Discussion section (lines 481 to 494; and lines 544 to 546) to provide further context on its role as a supplementary reinforcement activity.</p>
<p>Comment 5: Lines 486 to 489. A sentence is repeated.</p>
<p>Response: The repeated sentence has been removed.</p>
<p>________________________________________</p>
<p>We hope that our revisions adequately address the concerns raised. Please let us know if further modifications are required. Once again, we appreciate the reviewer’s and editor’s valuable feedback, which has helped us improve our manuscript.</p>
<p>Thank you for your time and consideration.</p>
<p>Best regards,</p>
<p>Dr. Rafdzah Ahmad Zaki</p>
<p>Public Health Medicine Specialist and Professor,</p>
<p>Department of Social and Preventive Medicine,</p>
<p>Faculty of Medicine</p>
<p>Universiti Malaya, Malaysia</p>
<p>rafdzah@ummc.edu.my</p>
<section class="sm xbox font-sm" id="pone.0328713.s005"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers_3 July 2025.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s005.docx</a><sup> (33.3KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0328713.r005"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0328713.r005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713.r005</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 2</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Ali Ahmed</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Ali Ahmed</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Ahmed</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.g" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.g" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.g" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Ali Ahmed</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.g" class="d-panel p" style="display: none">
<div>© 2025 Ali Ahmed</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>6 Jul 2025</em>
</p>
<p>Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia.</p>
<p>PONE-D-24-57343R2</p>
<p>Dear Dr. Rafdzah,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Editorial Manager®</a>  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>Kind regards,</p>
<p>Ali Ahmed, PhD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="pone.0328713.r006"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0328713.r006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0328713.r006</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Ali Ahmed</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Ali Ahmed</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmed%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Ahmed</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.h" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.h" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.h" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Ali Ahmed</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.h" class="d-panel p" style="display: none">
<div>© 2025 Ali Ahmed</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>PONE-D-24-57343R2</p>
<p>PLOS ONE</p>
<p>Dear Dr. Zaki,</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at <a href="https://explore.plos.org/phishing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://explore.plos.org/phishing</a>.</p>
<p>If we can help with anything else, please email us at customercare@plos.org.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
<p>Kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Ali Ahmed</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 File. Pre- and post-training knowledge test questionnaire.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s001.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s001.docx</a><sup> (19.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 File. Post-training feedback form.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s002.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s002.docx</a><sup> (15.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s004.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s004.docx</a><sup> (48.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers_3 July 2025.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12360552/bin/pone.0328713.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0328713.s005.docx</a><sup> (33.3KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The relevant data are available in the Harvard Dataverse at <a href="https://doi.org/10.7910/DVN/BONKBK" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.7910/DVN/BONKBK</a>.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0328713"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0328713.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (436.9 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12360552/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12360552/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12360552%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12360552/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12360552/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12360552/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40824910/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12360552/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40824910/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12360552/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12360552/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="i4cKGwKh07TTtuqm8Wnt7Bh09hm3MdjQafCkblo2LpOtCORpH2BUMLGhztSoALQE">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
